<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Isotretinoin - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Isotretinoin" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Isotretinoin&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Isotretinoin&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Isotretinoin" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Isotretinoin" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Isotretinoin","wgTitle":"Isotretinoin","wgCurRevisionId":670094164,"wgRevisionId":670094164,"wgArticleId":229985,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Wikipedia articles needing page number citations from October 2010","Wikipedia articles needing page number citations from May 2012","All articles lacking reliable references","Articles lacking reliable references from August 2013","CS1 German-language sources (de)","CS1 errors: dates","CS1 uses Greek-language script (el)","CS1 Greek-language sources (el)","Articles lacking reliable references from April 2012","Chemical articles having calculated molecular weight overwritten","Drugboxes which contain changes to watched fields","All articles with unsourced statements","Articles with unsourced statements from August 2013","Articles that use a Medicine navs subtemplate","Retinoids","Anti-acne preparations"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Isotretinoin","wgRelevantArticleId":229985,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Isotretinoin_embryopathy","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/7/75/Isotretinoin2DACS2.svg/100px-Isotretinoin2DACS2.svg.png","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Isotretinoin","wgWikibaseItemId":"Q287029"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Isotretinoin skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Isotretinoin</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Isotretinoin_embryopathy&amp;redirect=no" title="Isotretinoin embryopathy">Isotretinoin embryopathy</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em;border-spacing:2px;">
<caption>Isotretinoin</caption>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Isotretinoin2DACS2.svg" class="image"><img alt="Isotretinoin2DACS2.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/Isotretinoin2DACS2.svg/220px-Isotretinoin2DACS2.svg.png" width="220" height="124" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/Isotretinoin2DACS2.svg/330px-Isotretinoin2DACS2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/75/Isotretinoin2DACS2.svg/440px-Isotretinoin2DACS2.svg.png 2x" data-file-width="715" data-file-height="404" /></a></td>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Isotretinoin3d.svg" class="image"><img alt="Isotretinoin3d.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Isotretinoin3d.svg/220px-Isotretinoin3d.svg.png" width="220" height="94" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Isotretinoin3d.svg/330px-Isotretinoin3d.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Isotretinoin3d.svg/440px-Isotretinoin3d.svg.png 2x" data-file-width="948" data-file-height="407" /></a></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</th>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div style="word-wrap:break-word; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size:11px">(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Clinical data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Trade_name" title="Trade name">Trade names</a></th>
<td>Accutane</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugs.com/monograph/isotretinoin.html">monograph</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/druginfo/meds/a681043.html">a681043</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></th>
<td><a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration" class="mw-redirect">US&#160;FDA</a>:<span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Isotretinoin&amp;SearchType=BasicSearch">link</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br />
category</a></th>
<td>
<div class="plainlist">
<ul>
<li><small><abbr title="Australia">AU</abbr>:</small> <a href="/wiki/Pregnancy_category#Australia" title="Pregnancy category">X</a> (High risk)</li>
<li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Pregnancy_category#United_States" title="Pregnancy category">X</a> (Contraindicated)</li>
</ul>
</div>
</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th>
<td>
<div class="plainlist">
<ul>
<li><small><abbr title="Australia">AU</abbr>:</small> <a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons" class="mw-redirect">Prescription Only (S4)</a></li>
<li><small><abbr title="United Kingdom">UK</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug">Prescription-only</a> (POM)</li>
<li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span>-only</a></li>
</ul>
</div>
</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br />
administration</a></th>
<td>Oral, topical</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th>
<td>Variable</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th>
<td>99.9%</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th>
<td><a href="/wiki/Liver" title="Liver">Hepatic</a></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Biological_half-life" title="Biological half-life">Biological half-life</a></th>
<td>10–20 hours</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></th>
<td><a href="/wiki/Kidney" title="Kidney">Renal</a> and <a href="/wiki/Feces" title="Feces">fecal</a></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Identifiers</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Registry Number</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=4759-48-2&amp;rn=1">4759-48-2</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th>
<td><a href="/wiki/ATC_code_D10" title="ATC code D10">D10</a><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.whocc.no/atc_ddd_index/?code=D10AD04">AD04</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/PubChem" title="PubChem">PubChem</a></th>
<td>CID: <span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="//pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5282379">5282379</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/IUPHAR/BPS" title="IUPHAR/BPS" class="mw-redirect">IUPHAR/BPS</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7600">7600</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugbank.ca/drugs/DB00982">DB00982</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.chemspider.com/Chemical-Structure.4445539.html">4445539</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=EH28UP18IF">EH28UP18IF</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/KEGG" title="KEGG">KEGG</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.kegg.jp/entry/D00348">D00348</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6067">CHEBI:6067</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL547">CHEMBL547</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Chemical data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;--&gt;"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th>
<td><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>20</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>28</sub><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>2</sub></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;--&gt;"><a href="/wiki/Molecular_mass" title="Molecular mass">Molecular mass</a></th>
<td>300.44 g/mol</td>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification" class="mw-redirect">SMILES</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em">O=C(O)\C=C(/C=C/C=C(/C=C/C1=C(/CCCC1(C)C)C)C)C</div>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em">InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div>
</li>
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em">Key:SHGAZHPCJJPHSC-XFYACQKRSA-N<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png" width="14" height="14" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/21px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/28px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span>&#160;<a href="/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation" title="Wikipedia:WikiProject Chemicals/Chembox validation">(what is this?)</a>&#160;&#160;<span class="reflink plainlinks nourlexpansion"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=477168707&amp;page2=Isotretinoin">(verify)</a></span></th>
</tr>
</table>
<p><b>Isotretinoin</b> (<a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name">INN</a>) (<a href="/wiki/Tretinoin#Etymology_and_pronunciation" title="Tretinoin">etymology and pronunciation</a>), also known as <b>13-cis retinoic acid</b> and first marketed as <b>Accutane</b> by <a href="/wiki/Hoffmann-La_Roche" title="Hoffmann-La Roche">Hoffmann-La Roche</a>, is an oral <a href="/wiki/Medication" title="Medication" class="mw-redirect">medication</a> primarily used to treat <a href="/wiki/Acne_vulgaris" title="Acne vulgaris">cystic acne</a>. Rarely, it is also used to prevent certain skin cancers (<a href="/wiki/Squamous-cell_carcinoma" title="Squamous-cell carcinoma">squamous-cell carcinoma</a>), and in the treatment of other cancers. It is used to treat <a href="/wiki/Harlequin-type_ichthyosis" title="Harlequin-type ichthyosis">harlequin-type ichthyosis</a>, a usually lethal skin disease, and <a href="/wiki/Lamellar_ichthyosis" title="Lamellar ichthyosis">lamellar ichthyosis</a>. It is a <a href="/wiki/Retinoid" title="Retinoid">retinoid</a>, meaning it is related to <a href="/wiki/Vitamin_A" title="Vitamin A">vitamin A</a>, and is found in small quantities naturally in the body. Its <a href="/wiki/Isomer" title="Isomer">isomer</a>, <a href="/wiki/Tretinoin" title="Tretinoin">tretinoin</a>, is also an acne drug.</p>
<p>Isotretinoin is primarily used as a treatment for severe acne. The most common adverse effects are a transient worsening of acne (lasting 2–3 weeks), dry lips (<a href="/wiki/Cheilitis" title="Cheilitis">cheilitis</a>), dry and fragile skin, and an increased susceptibility to sunburn. Uncommon and rare side effects include: muscle aches and pains (myalgias), and headaches. Isotretinoin is known to cause <a href="/wiki/Teratogen" title="Teratogen" class="mw-redirect">birth defects</a> due to in utero exposure because of the molecule's close resemblance to <a href="/wiki/Retinoic_acid" title="Retinoic acid">retinoic acid</a>, a natural vitamin A derivative which controls normal embryonic development.</p>
<p>In the United States a special procedure is required to obtain the pharmaceutical. In most other countries a consent form is required which explains these risks. Women taking isotretinoin must not get pregnant during, and for 1 month after isotretinoin therapy. Sexual abstinence, or effective contraception is mandatory during this period. Barrier methods by themselves (such as condoms) are not considered adequate due to the unacceptable failure rates of approximately 3%. Women who fall pregnant whilst on isotretinoin therapy are generally counselled to have a termination. Isotretinoin has no effect on male reproduction.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup></p>
<p>In 2009, Roche decided to remove Accutane from the US market after juries had awarded millions of dollars in damages to former Accutane users over <a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">inflammatory bowel disease</a> claims. Other common brands are <b>Roaccutane</b> (<a href="/wiki/Hoffman-La_Roche" title="Hoffman-La Roche" class="mw-redirect">Hoffman-La Roche</a>, known as <b>Accutane</b> in the United States before July 2009),<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>D 1<span>]</span></a></sup> <b>Amnesteem</b> (<a href="/wiki/Mylan_Laboratories_Inc." title="Mylan Laboratories Inc." class="mw-redirect">Mylan</a>),<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>D 2<span>]</span></a></sup> <b>Claravis</b> (<a href="/wiki/Teva_Pharmaceutical_Industries" title="Teva Pharmaceutical Industries">Teva</a>),<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>D 3<span>]</span></a></sup> <b>Absorica</b> (<a href="/wiki/Ranbaxy_Laboratories" title="Ranbaxy Laboratories">Ranbaxy</a>),<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>D 4<span>]</span></a></sup> <b>Isotroin</b> (<a href="/wiki/Cipla" title="Cipla">Cipla</a>), and <b>Epuris</b> (Cipher).<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>2<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Medical_uses"><span class="tocnumber">1</span> <span class="toctext">Medical uses</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Indications"><span class="tocnumber">1.1</span> <span class="toctext">Indications</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Prescribing_restrictions"><span class="tocnumber">1.2</span> <span class="toctext">Prescribing restrictions</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Dosage"><span class="tocnumber">1.3</span> <span class="toctext">Dosage</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Adverse_effects"><span class="tocnumber">2</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Possible_permanent_effects"><span class="tocnumber">2.1</span> <span class="toctext">Possible permanent effects</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Skin"><span class="tocnumber">2.2</span> <span class="toctext">Skin</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Teratogenicity"><span class="tocnumber">2.3</span> <span class="toctext">Teratogenicity</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Psychological_effects"><span class="tocnumber">2.4</span> <span class="toctext">Psychological effects</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-10"><a href="#Mechanism_of_action"><span class="tocnumber">3</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1 tocsection-11"><a href="#Pharmacokinetics"><span class="tocnumber">4</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#History"><span class="tocnumber">5</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a>
<ul>
<li class="toclevel-2 tocsection-15"><a href="#Drugs.40FDA_references"><span class="tocnumber">7.1</span> <span class="toctext">Drugs@FDA references</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Medical_uses">Medical uses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=1" title="Edit section: Medical uses">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Isotretinoin is used primarily for severe cystic acne and acne that has not responded to other treatments.<sup id="cite_ref-pmid19588674_7-0" class="reference"><a href="#cite_note-pmid19588674-7"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-pmid20436884_8-0" class="reference"><a href="#cite_note-pmid20436884-8"><span>[</span>4<span>]</span></a></sup> Acne treatment usually begins with topical retinoids (e.g., tretinoin, <a href="/wiki/Adapalene" title="Adapalene">adapalene</a>), in combination with topical antibiotics (e.g., clindamycin, erythromycin) or antiseptics (e.g., benzoyl peroxide-containing preparations), followed by oral antibiotics (e.g., doxycycline or minocycline). In women a <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a>-containing contraceptive pill can be useful if there are no contraindications.</p>
<p>In cases of hormonal acne, such as in women in their 20s and 30s with cyclical acne, often a course of isotretinoin can permanently improve acne obviating the need for lifelong hormonal manipulation.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (August 2013)">medical citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Indications">Indications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=2" title="Edit section: Indications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The primary indication for Isotretinoin is the treatment of severe cystic <a href="/wiki/Acne_vulgaris" title="Acne vulgaris">acne vulgaris</a>.<sup id="cite_ref-AMH2006_9-0" class="reference"><a href="#cite_note-AMH2006-9"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-Micromedex_10-0" class="reference"><a href="#cite_note-Micromedex-10"><span>[</span>6<span>]</span></a></sup> Many dermatologists also support its use for treatment of lesser degrees of acne that prove resistant to other treatments, or that produce physical or psychological scarring.<sup id="cite_ref-pmid17276540_11-0" class="reference"><a href="#cite_note-pmid17276540-11"><span>[</span>7<span>]</span></a></sup></p>
<p>It is also somewhat effective for <a href="/wiki/Hidradenitis_suppurativa" title="Hidradenitis suppurativa">hidradenitis suppurativa</a> and some cases of severe <a href="/wiki/Acne_rosacea" title="Acne rosacea" class="mw-redirect">acne rosacea</a>.<sup id="cite_ref-Micromedex_10-1" class="reference"><a href="#cite_note-Micromedex-10"><span>[</span>6<span>]</span></a></sup> It can also be used to help treat <a href="/wiki/Harlequin-type_ichthyosis" title="Harlequin-type ichthyosis">harlequin ichthyosis</a>, lamellar ichthyosis and is used in <a href="/wiki/Xeroderma_pigmentosum" title="Xeroderma pigmentosum">xeroderma pigmentosum</a> cases to relieve <a href="/wiki/Keratose" title="Keratose" class="mw-redirect">keratoses</a>. Isotretinoin has been used to treat the extremely rare condition <a href="/wiki/Fibrodysplasia_ossificans_progressiva" title="Fibrodysplasia ossificans progressiva">fibrodysplasia ossificans progressiva</a>. It is also used for treatment of <a href="/wiki/Neuroblastoma" title="Neuroblastoma">neuroblastoma</a>, a form of nerve cancer.</p>
<p>Isotretinoin therapy has furthermore proven effective against <a href="/wiki/Genital_warts" title="Genital warts" class="mw-redirect">genital warts</a> in experimental use, but is rarely used for this indication as there are more effective treatments. Isotretinoin may represent an efficacious and safe alternative systemic form of therapy for RCA of the cervix. In most countries this therapy is currently unapproved and only used if other therapies failed.<sup id="cite_ref-Oral_isotretinoin_Therapy_12-0" class="reference"><a href="#cite_note-Oral_isotretinoin_Therapy-12"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-Unapproved_Isotretinoin_13-0" class="reference"><a href="#cite_note-Unapproved_Isotretinoin-13"><span>[</span>9<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Prescribing_restrictions">Prescribing restrictions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=3" title="Edit section: Prescribing restrictions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Isoretinoin is a <a href="/wiki/Teratogen" title="Teratogen" class="mw-redirect">teratogen</a>; there is about a 20%–35% risk for congenital defects in infants exposed to the drug <i>in utero</i>, and about 30%–60% of children exposed to isotretinoin prenatally have been reported to show neurocognitive impairment.<sup id="cite_ref-Choi2013_14-0" class="reference"><a href="#cite_note-Choi2013-14"><span>[</span>10<span>]</span></a></sup> Because of this, there are strict controls on prescribing isoretinoin to women who may become pregrant and women who become pregnant while taking isoretinoin are strongly advised to terminate their pregnancies.<sup id="cite_ref-Choi2013_14-1" class="reference"><a href="#cite_note-Choi2013-14"><span>[</span>10<span>]</span></a></sup></p>
<p>In most countries, isotretinoin can only be prescribed by dermatologists or specialist physicians; some countries also allow limited prescription by general practitioners and family doctors. In the United Kingdom<sup id="cite_ref-BNF47_15-0" class="reference"><a href="#cite_note-BNF47-15"><span>[</span>11<span>]</span></a></sup> and Australia,<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>13<span>]</span></a></sup> isotretinoin may be prescribed only by or under the supervision of a consultant <a href="/wiki/Dermatologist" title="Dermatologist" class="mw-redirect">dermatologist</a>. Because severe cystic acne has the potential to cause permanent scarring over a short period, restrictions on its more immediate availability have proved contentious.<sup id="cite_ref-James_1996_18-0" class="reference"><a href="#cite_note-James_1996-18"><span>[</span>14<span>]</span></a></sup> In New Zealand, isotretinoin can be prescribed by any doctor but subsidised only when prescribed by a vocationally-registered general practitioner, dermatologist or nurse practitioner.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>15<span>]</span></a></sup></p>
<p>In the United States, dispensing of isotretinoin is by an <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a>-mandated website called <a href="/wiki/IPLEDGE" title="IPLEDGE">iPLEDGE</a>. iPLEDGE has applied to isotretinoin prescriptions since 1 March 2006. Under it, dermatologists must register their patients on the system before prescribing isotretinoin. Pharmacists must then verify the prescription on the iPLEDGE website before dispensing isotretinoin. The website allows no more than thirty days' supply of the drug to be prescribed or dispensed; and after issuance, another prescription may not be written for at least 30 days (even in the case of lost prescriptions). Prescriptions expire from iPLEDGE if not picked up from the pharmacy seven days after issuance. Physicians and pharmacists must verify written prescriptions on the system before filling an isotretinoin prescription. Due to the teratogenic effects of isotretinoin, iPLEDGE makes additional requirements of female patients filling prescriptions for the drug: women with child-bearing potential must commit to using two forms of effective contraception simultaneously for the duration of isotretinoin therapy and for a month immediately preceding and a month immediately following therapy.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>16<span>]</span></a></sup> Alerts continue to exist against purchasing isotretinoin online.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>17<span>]</span></a></sup></p>
<p>Most other national health services emphasise that isotretinoin is a teratogen, but do not impose the same stringent conditions on the dispensing process as the United States does. In Mexico and Brazil the use of the drug is restricted: official identification and a signature must be provided by the patient before an isotretinoin prescription will be filled by a pharmacist.</p>
<p>Clinical guidelines for most countries recommends or mandates that the dispensing physician monitor patients, or provide instructions to the patient's regular doctor for monitoring. As part of the monitoring, patients' blood is periodically re-tested throughout treatment for blood lipids, pregnancy, and several other factors. Women, diabetics, and patients with liver problems are particularly at risk and will be monitored especially closely.</p>
<h3><span class="mw-headline" id="Dosage">Dosage</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=4" title="Edit section: Dosage">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="/wiki/File:Roaccutane.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Roaccutane.JPG/200px-Roaccutane.JPG" width="200" height="150" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Roaccutane.JPG/300px-Roaccutane.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Roaccutane.JPG/400px-Roaccutane.JPG 2x" data-file-width="1280" data-file-height="960" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Roaccutane.JPG" class="internal" title="Enlarge"></a></div>
10 mg capsule</div>
</div>
</div>
<p>The dose of isotretinoin patients receive is dependent on their weight and the severity of the condition. High-dose treatments are administered between 0.5&#160;mg/kg/day to 2&#160;mg/kg/day (usually at 0.5 to 1&#160;mg/kg/day,<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>18<span>]</span></a></sup> given as a single dose with food). Usually a course will last 8–10 months. A second course may be required. Efficacy appears to be related to the cumulative dose of isotretinoin taken, with a total cumulative dose over each course of 120–150&#160;mg/kg used as a guideline.<sup id="cite_ref-AMH2006_9-1" class="reference"><a href="#cite_note-AMH2006-9"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-Micromedex_10-2" class="reference"><a href="#cite_note-Micromedex-10"><span>[</span>6<span>]</span></a></sup></p>
<p>Nearly all patients achieve initial clearing of acne during a normal course of isotretinoin therapy. 90% of patients achieve excellent clearance of their acne after a cumulative dose of 150&#160;mg/kg.</p>
<p>Lower-dosage treatments, such as 10–20&#160;mg/day (approximately half the high dosage treatments above), can also be effective, with greatly diminished side effects.<sup id="cite_ref-Amichai_2006_23-0" class="reference"><a href="#cite_note-Amichai_2006-23"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-Seukeran_1998_24-0" class="reference"><a href="#cite_note-Seukeran_1998-24"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-pmid8112947_25-0" class="reference"><a href="#cite_note-pmid8112947-25"><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-pmid9784036_26-0" class="reference"><a href="#cite_note-pmid9784036-26"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-pmid9933749_27-0" class="reference"><a href="#cite_note-pmid9933749-27"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-pmid8129410_28-0" class="reference"><a href="#cite_note-pmid8129410-28"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>25<span>]</span></a></sup> However, such lower dosage courses may be associated with higher relapse rates, requiring additional courses, especially if not taken for sufficient time.<sup id="cite_ref-James2005_30-0" class="reference"><a href="#cite_note-James2005-30"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-pmid16484812_31-0" class="reference"><a href="#cite_note-pmid16484812-31"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid16409263_32-0" class="reference"><a href="#cite_note-pmid16409263-32"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-pmid17970803_33-0" class="reference"><a href="#cite_note-pmid17970803-33"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-pmid19067687_34-0" class="reference"><a href="#cite_note-pmid19067687-34"><span>[</span>30<span>]</span></a></sup></p>
<p>Usually, a starting dose of 20&#160;mg is taken with the largest meal of the day. After a few months, the dose is increased, e.g., to 40&#160;mg/d. If side-effects permit, a higher dose such as 60&#160;mg/d can be prescribed although daily dose rarely exceeds 60&#160;mg. If 20&#160;mg capsules are supplied, patients may take (for example) 20&#160;mg one day, then 40&#160;mg the next to provide an average daily dose of 30&#160;mg/d. In most cases, isotretinoin achieves a complete clearing of acne during a standard-dose 12–16 week course. Some patients' acne will respond to a course before recurring, necessitating multiple courses of treatment.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>31<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Adverse_effects">Adverse effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=5" title="Edit section: Adverse effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Increasingly higher dosages will result in higher toxicity, resembling <a href="/wiki/Vitamin_A_toxicity" title="Vitamin A toxicity" class="mw-redirect">vitamin A toxicity</a>. The following are adverse drug reactions from Roche's UK product information for Roaccutane as of October 2010:<sup id="cite_ref-urlIsotretinoin_20mg_capsules_-_Summary_of_Product_Characteristics_.28SPC.29_-_.28eMC.29_36-0" class="reference"><a href="#cite_note-urlIsotretinoin_20mg_capsules_-_Summary_of_Product_Characteristics_.28SPC.29_-_.28eMC.29-36"><span>[</span>32<span>]</span></a></sup></p>
<table class="wikitable">
<tr>
<th>
<p>Type of disorders</p>
</th>
<th>
<p>Very common (≥ 1/10)</p>
</th>
<th>
<p>Common (≥ 1/100, &lt; 1/10)</p>
</th>
<th>
<p>Rare (≥ 1/10 000,&lt; 1/1000)</p>
</th>
<th>
<p>Very rare (≤ 1/10 000)</p>
</th>
</tr>
<tr>
<td><b>Infections</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li>Gram positive (mucocutaneous)</li>
</ul>
<p>bacterial infection</p>
</td>
</tr>
<tr>
<td><b>Blood and <a href="/wiki/Lymphatic_system" title="Lymphatic system">lymphatic system</a></b></td>
<td>
<ul>
<li><a href="/wiki/Anemia" title="Anemia">Anemia</a></li>
<li>Increased red blood cell sedimentation rate</li>
<li><a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">Thrombocytopenia</a></li>
<li><a href="/wiki/Thrombocytosis" title="Thrombocytosis">Thrombocytosis</a></li>
</ul>
</td>
<td>
<ul>
<li><a href="/wiki/Neutropenia" title="Neutropenia">Neutropenia</a></li>
</ul>
</td>
<td></td>
<td>
<ul>
<li>Lymphadenopathy</li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Immune_system" title="Immune system">Immune system</a></b></td>
<td></td>
<td></td>
<td>
<ul>
<li>Allergic skin reaction</li>
<li><a href="/wiki/Anaphylactic" title="Anaphylactic" class="mw-redirect">Anaphylactic</a> reactions</li>
<li>Hypersensitivity</li>
</ul>
</td>
<td></td>
</tr>
<tr>
<td><b><a href="/wiki/Metabolism" title="Metabolism">Metabolism</a></b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">Diabetes mellitus</a></li>
<li><a href="/wiki/Hyperuricaemia" title="Hyperuricaemia" class="mw-redirect">Hyperuricaemia</a></li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Psychiatric" title="Psychiatric" class="mw-redirect">Psychiatric</a></b></td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Depression_(mood)" title="Depression (mood)">Depression</a></li>
<li>Aggravated depression</li>
<li>Aggressive tendencies</li>
<li><a href="/wiki/Anxiety" title="Anxiety">Anxiety</a></li>
<li>Mood alterations</li>
</ul>
</td>
<td>
<ul>
<li>Abnormal behaviour</li>
<li>Psychotic disorder</li>
<li>Suicidal ideation</li>
<li>Suicide attempt</li>
<li>Suicide</li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Nervous_system" title="Nervous system">Nervous system</a></b></td>
<td></td>
<td>
<ul>
<li>Headache</li>
</ul>
</td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Benign_intracranial_hypertension" title="Benign intracranial hypertension" class="mw-redirect">Benign intracranial hypertension</a></li>
<li><a href="/wiki/Convulsions" title="Convulsions" class="mw-redirect">Convulsions</a></li>
<li><a href="/wiki/Drowsiness" title="Drowsiness" class="mw-redirect">Drowsiness</a></li>
<li><a href="/wiki/Dizziness" title="Dizziness">Dizziness</a></li>
</ul>
</td>
</tr>
<tr>
<td><b>Eye</b></td>
<td>
<ul>
<li><a href="/wiki/Blepharitis" title="Blepharitis">Blepharitis</a></li>
<li><a href="/wiki/Conjunctivitis" title="Conjunctivitis">Conjunctivitis</a></li>
<li><a href="/wiki/Keratoconjunctivitis_sicca" title="Keratoconjunctivitis sicca">Dry eyes</a></li>
<li>Eye irritation</li>
</ul>
</td>
<td></td>
<td></td>
<td>
<ul>
<li>Blurred vision</li>
<li><a href="/wiki/Cataract" title="Cataract">Cataract</a></li>
<li><a href="/wiki/Colour_blindness" title="Colour blindness" class="mw-redirect">Colour blindness</a></li>
<li>Contact lens intolerance</li>
<li>Corneal opacity</li>
<li>Decreased night vision</li>
<li><a href="/wiki/Keratitis" title="Keratitis">Keratitis</a></li>
<li><a href="/wiki/Papilloedema" title="Papilloedema" class="mw-redirect">Papilloedema</a></li>
<li><a href="/wiki/Photophobia" title="Photophobia">Photophobia</a></li>
<li>Visual disturbances</li>
</ul>
</td>
</tr>
<tr>
<td><b>Ear</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li>Impaired hearing</li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Vascular" title="Vascular" class="mw-redirect">Vascular</a></b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Vasculitis" title="Vasculitis">Vasculitis</a> (i.e. <a href="/wiki/Wegener%27s_granulomatosis" title="Wegener's granulomatosis" class="mw-redirect">Wegener's granulomatosis</a>,</li>
</ul>
<p>allergic vasculitis)</p>
</td>
</tr>
<tr>
<td><b>Respiratory, <a href="/wiki/Thoracic" title="Thoracic" class="mw-redirect">thoracic</a> and<br /></b>
<p><a href="/wiki/Mediastinal" title="Mediastinal" class="mw-redirect">mediastinal</a></p>
</td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Epistaxis" title="Epistaxis" class="mw-redirect">Epistaxis</a></li>
<li>Nasal dryness</li>
<li><a href="/wiki/Nasopharyngitis" title="Nasopharyngitis" class="mw-redirect">Nasopharyngitis</a></li>
</ul>
</td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Bronchospasm" title="Bronchospasm">Bronchospasm</a> (particularly in patients</li>
</ul>
<p>with asthma)</p>
<ul>
<li><a href="/wiki/Hoarseness" title="Hoarseness" class="mw-redirect">Hoarseness</a></li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Gastrointestinal" title="Gastrointestinal" class="mw-redirect">Gastrointestinal</a></b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Colitis" title="Colitis">Colitis</a></li>
<li><a href="/wiki/Ileitis" title="Ileitis">Ileitis</a></li>
<li>Dry throat</li>
<li><a href="/wiki/Gastrointestinal_haemorrhage" title="Gastrointestinal haemorrhage" class="mw-redirect">Gastrointestinal haemorrhage</a></li>
<li>Haemorrhagic diarrhoea</li>
<li><a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">Inflammatory bowel disease</a></li>
<li><a href="/wiki/Nausea" title="Nausea">Nausea</a></li>
<li><a href="/wiki/Pancreatitis" title="Pancreatitis">Pancreatitis</a></li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Hepatobiliary" title="Hepatobiliary" class="mw-redirect">Hepatobiliary</a></b></td>
<td>
<ul>
<li>Increased <a href="/wiki/Transaminase" title="Transaminase">transaminase</a></li>
</ul>
</td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Hepatitis" title="Hepatitis">Hepatitis</a></li>
</ul>
</td>
</tr>
<tr>
<td><b>Skin and<br /></b>
<p><a href="/wiki/Subcutaneous_tissues" title="Subcutaneous tissues" class="mw-redirect">subcutaneous tissues</a></p>
</td>
<td>
<ul>
<li><a href="/wiki/Cheilitis" title="Cheilitis">Cheilitis</a></li>
<li><a href="/wiki/Dermatitis" title="Dermatitis">Dermatitis</a></li>
<li><a href="/wiki/Xeroderma" title="Xeroderma">Dry skin</a></li>
<li>Localised exfoliation</li>
<li><a href="/wiki/Pruritus" title="Pruritus" class="mw-redirect">Pruritus</a></li>
<li>Rash</li>
<li><a href="/wiki/Erythematous" title="Erythematous" class="mw-redirect">Erythematous</a></li>
<li>Skin fragility</li>
</ul>
</td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Alopecia" title="Alopecia" class="mw-redirect">Alopecia</a></li>
</ul>
</td>
<td>
<ul>
<li><a href="/wiki/Acne_fulminans" title="Acne fulminans">Acne fulminans</a></li>
<li>Aggravated acne (acne flare)</li>
<li><a href="/wiki/Erythema" title="Erythema">Erythema</a> (facial)</li>
<li><a href="/wiki/Exanthema" title="Exanthema" class="mw-redirect">Exanthema</a></li>
<li>Hair disorders</li>
<li><a href="/wiki/Hirsutism" title="Hirsutism">Hirsutism</a></li>
<li><a href="/wiki/Nail_dystrophy" title="Nail dystrophy" class="mw-redirect">Nail dystrophy</a></li>
<li><a href="/wiki/Paronychia" title="Paronychia">Paronychia</a></li>
<li><a href="/wiki/Photosensitivity_reaction" title="Photosensitivity reaction" class="mw-redirect">Photosensitivity reaction</a></li>
<li><a href="/wiki/Pyogenic_granuloma" title="Pyogenic granuloma">Pyogenic granuloma</a></li>
<li>Skin <a href="/wiki/Hyperpigmentation" title="Hyperpigmentation">hyperpigmentation</a></li>
<li>Increased sweating</li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Musculo-skeletal" title="Musculo-skeletal" class="mw-redirect">Musculo-skeletal</a> and<br /></b>
<p><a href="/wiki/Connective_tissue" title="Connective tissue">connective tissue</a></p>
</td>
<td>
<ul>
<li><a href="/wiki/Arthralgia" title="Arthralgia">Arthralgia</a></li>
<li><a href="/wiki/Myalgia" title="Myalgia">Myalgia</a></li>
<li>Back pain</li>
</ul>
</td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a></li>
<li><a href="/wiki/Calcinosis" title="Calcinosis">Calcinosis</a> (calcification of ligaments</li>
</ul>
<p>and tendons)</p>
<ul>
<li>Premature epiphyseal fusion</li>
<li><a href="/wiki/Exostosis" title="Exostosis">Exostosis</a></li>
<li><a href="/wiki/Hyperostosis" title="Hyperostosis">Hyperostosis</a></li>
<li><a href="/wiki/Osteopenia" title="Osteopenia">Osteopenia</a></li>
<li><a href="/wiki/Tendonitis" title="Tendonitis" class="mw-redirect">Tendonitis</a></li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Renal" title="Renal" class="mw-redirect">Renal</a> and <a href="/wiki/Urinary" title="Urinary" class="mw-redirect">urinary</a></b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li><a href="/wiki/Glomerulonephritis" title="Glomerulonephritis">Glomerulonephritis</a></li>
</ul>
</td>
</tr>
<tr>
<td><b>General</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul>
<li>Increased formation of <a href="/wiki/Granulation_tissue" title="Granulation tissue">granulation tissue</a></li>
<li><a href="/wiki/Malaise" title="Malaise">Malaise</a></li>
</ul>
</td>
</tr>
<tr>
<td><b>Investigation</b></td>
<td>
<ul>
<li>Increased <a href="/wiki/Triglycerides" title="Triglycerides" class="mw-redirect">triglycerides</a></li>
<li>Decreased <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">HDL</a></li>
</ul>
</td>
<td>
<ul>
<li>Increased blood cholesterol</li>
<li>Increased blood glucose</li>
<li><a href="/wiki/Haematuria" title="Haematuria" class="mw-redirect">Haematuria</a></li>
<li><a href="/wiki/Proteinuria" title="Proteinuria">Proteinuria</a></li>
</ul>
</td>
<td></td>
<td>
<ul>
<li>Increased <a href="/wiki/Creatine_phosphokinase" title="Creatine phosphokinase" class="mw-redirect">creatine phosphokinase</a></li>
</ul>
</td>
</tr>
</table>
<p>Research suggests <a href="/wiki/Vitamin_E" title="Vitamin E">vitamin E</a> supplementation in the form of alpha-tocopherol reduces the toxicity of isotretinoin treatment in subjects with cancer<sup id="cite_ref-pmid9093712_37-0" class="reference"><a href="#cite_note-pmid9093712-37"><span>[</span>33<span>]</span></a></sup> and <a href="/wiki/Myelodysplastic_syndrome" title="Myelodysplastic syndrome">myelodysplastic syndrome</a>.<sup id="cite_ref-pmid2252043_38-0" class="reference"><a href="#cite_note-pmid2252043-38"><span>[</span>34<span>]</span></a></sup> In contrast, a randomized study in 82 subjects taking isotretinoin (1&#160;mg/kg/day) for acne vulgaris found no difference in the incidence or severity of side effects in the group taking an additional 800 IU/day of vitamin E in the form of d-l-alphatocopherol.<sup id="cite_ref-Kus_2005_39-0" class="reference"><a href="#cite_note-Kus_2005-39"><span>[</span>35<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Possible_permanent_effects">Possible permanent effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=6" title="Edit section: Possible permanent effects">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>An Accutane medication guide approved by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> in 2010 states that the drug "may stop <a href="/wiki/Long_bone" title="Long bone">long bone</a> growth in teenagers who are still growing."<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>D 5<span>]</span></a></sup> Several reports state that premature <a href="/wiki/Epiphyseal" title="Epiphyseal" class="mw-redirect">epiphyseal</a> closure can occur in acne patients receiving recommended doses of Accutane.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45"><span>[</span>40<span>]</span></a></sup></p>
<p>Several scientific studies have posited isotretinoin as a possible cause of <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> and <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a> in some individuals.<sup id="cite_ref-pmid20354506_46-0" class="reference"><a href="#cite_note-pmid20354506-46"><span>[</span>41<span>]</span></a></sup></p>
<p>However, a study looking at 45,000 patients showed no association between isotretinoin and inflammatory bowel disease (Ulcerative Colitis and Crohn's Disease).<sup id="cite_ref-pmid23426479_47-0" class="reference"><a href="#cite_note-pmid23426479-47"><span>[</span>42<span>]</span></a></sup> The authors concluded, "Because inflammatory acne in children and adolescents carries a high psychological burden, clinicians should not be discouraged from prescribing this drug owing to a putative association with IBD."</p>
<p>Decreased <a href="/wiki/Night_vision" title="Night vision">night vision</a> and <a href="/wiki/Keratoconjunctivitis_sicca" title="Keratoconjunctivitis sicca">keratoconjunctivitis sicca</a> (dry eyes) has been reported to persist in some patients after discontinuation of isotretinoin therapy.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>43<span>]</span></a></sup><sup id="cite_ref-autogenerated299_49-0" class="reference"><a href="#cite_note-autogenerated299-49"><span>[</span>44<span>]</span></a></sup></p>
<p><a href="/wiki/Hyperostosis" title="Hyperostosis">Hyperostosis</a> has been reported in patients receiving treatment with isotretinoin.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>45<span>]</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>46<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Skin">Skin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=7" title="Edit section: Skin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The most common side effects are muco-cutaneous: dry lips and skin. Regular lip balm and moisturizer is recommended. Sometimes, however, the dose needs to be decreased to reduce these side effects.<sup id="cite_ref-pmid16703787_52-0" class="reference"><a href="#cite_note-pmid16703787-52"><span>[</span>47<span>]</span></a></sup> The skin becomes more fragile—especially to frictional forces—and may not heal as quickly as normal. For this reason waxing of hair, tattooing, tattoo removal, piercings, dermabrasion, exfoliation, etc. are not recommended. Treatment of acne scars (e.g., with fractional laser such as "Fraxel") is generally deferred until 12 months after completion of a course of isotretinoin.</p>
<p>Acne usually flares up 2–3 weeks into the treatment and is usually mild and tolerable. Occasionally this flareup is severe, necessitating oral antiobiotics such as erythromycin. A short course of oral prednisolone may be required. Some dermatologists favour a few weeks pre-treatment with oral antibiotics before commencing isotretinoin to reduce the chance of a severe flare.</p>
<h3><span class="mw-headline" id="Teratogenicity">Teratogenicity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=8" title="Edit section: Teratogenicity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><span id="Teratogenicity_.28Birth_defects.29"></span><span id="Teratogenicity_.28birth_defects.29"></span> Isotretinoin is a <a href="/wiki/Teratogen" title="Teratogen" class="mw-redirect">teratogen</a> highly likely to cause birth defects if taken by women during pregnancy or even a short time before conception. A few of the more common birth defects this drug can cause are hearing and visual impairment, missing or malformed earlobes, facial dysmorphism, and mental retardation. Isotretinoin is classified as <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> <a href="/wiki/Pregnancy_category_(pharmaceutical)" title="Pregnancy category (pharmaceutical)" class="mw-redirect">Pregnancy Category</a> X and <a href="/wiki/Australian_Drug_Evaluation_Committee" title="Australian Drug Evaluation Committee">ADEC</a> Category X, and use is contraindicated in pregnancy.<sup id="cite_ref-Micromedex_10-3" class="reference"><a href="#cite_note-Micromedex-10"><span>[</span>6<span>]</span></a></sup></p>
<p>The manufacturer recommends pregnancy be excluded in female patients two weeks prior to commencement of isotretinoin, and they should use two simultaneous forms of effective contraception at least one month prior to commencement, during, and for at least one month following isotretinoin therapy.<sup id="cite_ref-RoaccutanePI_53-0" class="reference"><a href="#cite_note-RoaccutanePI-53"><span>[</span>48<span>]</span></a></sup></p>
<p>In the <a href="/wiki/United_States" title="United States">U.S.</a>, more than 2,000 women have become pregnant while taking the drug between 1982 and 2003, with most pregnancies ending in <a href="/wiki/Abortion" title="Abortion">abortion</a> or <a href="/wiki/Miscarriage" title="Miscarriage">miscarriage</a>. About 160 babies with birth defects were born. As a consequence, the <a href="/wiki/IPLEDGE" title="IPLEDGE">iPLEDGE</a> program was introduced by the U.S. FDA on 12 August 2005 in an attempt to ensure female patients receiving isotretinoin do not become pregnant. As of 1 March 2006, only prescribers registered and activated in iPLEDGE are able to prescribe isotretinoin, and only patients registered and qualified in iPLEDGE will be able to have isotretinoin dispensed by a registered pharmacy. All patients, including women not of child-bearing age and men, must register with iPLEDGE. FDA's intent with the iPLEDGE program is to tightly control the distribution and dispensing of isotretinoin and thereby prevent the potential for distribution or sharing of the drug outside of the program to women of child-bearing age. In 2011, 155 pregnancies occurred among 129,544 women of childbearing potential taking isotrentinoin (0.12%)<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>49<span>]</span></a></sup></p>
<p>Patients receiving isotretinoin therapy are not permitted to donate blood during and for at least one month after discontinuation of therapy due to its teratogenicity.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>50<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Psychological_effects">Psychological effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=9" title="Edit section: Psychological effects">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The association between isotretinoin use and psychopathology has been controversial. Beginning in 1983, isolated case reports emerged suggesting mood change, particularly depression, occurring during or soon after isotretinoin use.<sup id="cite_ref-bjd2010_56-0" class="reference"><a href="#cite_note-bjd2010-56"><span>[</span>51<span>]</span></a></sup> A number of studies have been conducted since then of the drug's effect on depression, psychosis, suicidal thoughts and other psychological effects.<sup id="cite_ref-bjd2010_56-1" class="reference"><a href="#cite_note-bjd2010-56"><span>[</span>51<span>]</span></a></sup> Recent reviews of the studies and reports have found that an association has not been proven, with varying opinions on the likelihood of an association.<sup id="cite_ref-bjd2010_56-2" class="reference"><a href="#cite_note-bjd2010-56"><span>[</span>51<span>]</span></a></sup><sup id="cite_ref-dreno2008_57-0" class="reference"><a href="#cite_note-dreno2008-57"><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-kontaxakis2009_58-0" class="reference"><a href="#cite_note-kontaxakis2009-58"><span>[</span>53<span>]</span></a></sup></p>
<p>A 2008 review found that based on clinical studies and case reports, “the link between suicides and severe depressions has not yet been clearly demonstrated.”<sup id="cite_ref-dreno2008_57-1" class="reference"><a href="#cite_note-dreno2008-57"><span>[</span>52<span>]</span></a></sup> A 2009 review found that evidence strongly suggested a link between the use of isotretinoin and psychopathology, but did not establish a causal link. It recommended that “clinicians should be on the alert for potential psychiatric side effects following treatment with isotretinoin, especially in vulnerable populations.”<sup id="cite_ref-kontaxakis2009_58-1" class="reference"><a href="#cite_note-kontaxakis2009-58"><span>[</span>53<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mechanism_of_action">Mechanism of action</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=10" title="Edit section: Mechanism of action">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Isotretinoin's exact <a href="/wiki/Mechanism_of_action" title="Mechanism of action">mechanism of action</a> is unknown, but several studies have shown that isotretinoin induces <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a> (cell death) in various cells in the body. Cell death may be instigated in the <a href="/wiki/Meibomian_gland" title="Meibomian gland">meibomian glands</a>,<sup id="cite_ref-Lambert_1989_59-0" class="reference"><a href="#cite_note-Lambert_1989-59"><span>[</span>54<span>]</span></a></sup><sup id="cite_ref-Kremer1994_60-0" class="reference"><a href="#cite_note-Kremer1994-60"><span>[</span>55<span>]</span></a></sup> <a href="/wiki/Hypothalamic" title="Hypothalamic" class="mw-redirect">hypothalamic</a> cells,<sup id="cite_ref-Griffin_2010_61-0" class="reference"><a href="#cite_note-Griffin_2010-61"><span>[</span>56<span>]</span></a></sup> <a href="/wiki/Hippocampus" title="Hippocampus">hippocampus</a> cells<sup id="cite_ref-Crandall2004_62-0" class="reference"><a href="#cite_note-Crandall2004-62"><span>[</span>57<span>]</span></a></sup><sup id="cite_ref-Sakai_2004_63-0" class="reference"><a href="#cite_note-Sakai_2004-63"><span>[</span>58<span>]</span></a></sup> and—important for treatment of acne—in <a href="/wiki/Sebaceous_gland" title="Sebaceous gland">sebaceous gland</a> cells.<sup id="cite_ref-Nelson2011_64-0" class="reference"><a href="#cite_note-Nelson2011-64"><span>[</span>59<span>]</span></a></sup><sup id="cite_ref-Nelson_2006_65-0" class="reference"><a href="#cite_note-Nelson_2006-65"><span>[</span>60<span>]</span></a></sup> Isotretinoin has a low affinity for <a href="/wiki/Retinoic_acid_receptor" title="Retinoic acid receptor">retinoic acid receptors</a> (RAR) and <a href="/wiki/Retinoid_X_receptor" title="Retinoid X receptor">retinoid X receptors</a> (RXR), but may be converted intracellularly to metabolites that act as <a href="/wiki/Agonist" title="Agonist">agonists</a> of RAR and RXR <a href="/wiki/Nuclear_receptor" title="Nuclear receptor">nuclear receptors</a>.<sup id="cite_ref-pmid20436884_8-1" class="reference"><a href="#cite_note-pmid20436884-8"><span>[</span>4<span>]</span></a></sup></p>
<p>One study suggests the drug amplifies production of <a href="/wiki/LCN2" title="LCN2">neutrophil gelatinase-associated lipocalin</a> (NGAL) in the skin, which has been shown to reduce <a href="/wiki/Sebum" title="Sebum" class="mw-redirect">sebum</a> production by inducing apoptosis in sebaceous gland cells, while exhibiting an antimicrobial effect on <i>Propionibacterium acnes</i>.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>61<span>]</span></a></sup><sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>62<span>]</span></a></sup><sup id="cite_ref-pmid18317594_68-0" class="reference"><a href="#cite_note-pmid18317594-68"><span>[</span>63<span>]</span></a></sup> The drug decreases the size and sebum output of the sebaceous glands.<sup id="cite_ref-Peck_69-0" class="reference"><a href="#cite_note-Peck-69"><span>[</span>64<span>]</span></a></sup> Isotretinoin is the only available acne drug that affects all four major pathogenic processes in acne, which distinguishes it from alternative treatments (such as antibiotics) and accounts for its efficacy in severe, nodulocystic cases.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>65<span>]</span></a></sup> The effect of Isotretinoin on sebum production can be temporary,<sup id="cite_ref-FDA_71-0" class="reference"><a href="#cite_note-FDA-71"><span>[</span>66<span>]</span></a></sup> or remission of the disease can be "complete and prolonged."<sup id="cite_ref-Peck_69-1" class="reference"><a href="#cite_note-Peck-69"><span>[</span>64<span>]</span></a></sup><sup id="cite_ref-Farrell_72-0" class="reference"><a href="#cite_note-Farrell-72"><span>[</span>67<span>]</span></a></sup><sup id="cite_ref-Jones_73-0" class="reference"><a href="#cite_note-Jones-73"><span>[</span>68<span>]</span></a></sup></p>
<p>Isotretinoin has been speculated to down-regulate the <a href="/wiki/Telomerase" title="Telomerase">telomerase</a> enzyme and <a href="/wiki/HTERT" title="HTERT" class="mw-redirect">hTERT</a>, inhibiting "<a href="/wiki/Biological_immortality#Cell_lines" title="Biological immortality">cellular immortalization</a> and <a href="/wiki/Carcinogenesis" title="Carcinogenesis">tumorigenesis</a>."<sup id="cite_ref-Pendino_74-0" class="reference"><a href="#cite_note-Pendino-74"><span>[</span>69<span>]</span></a></sup> In a 2007 study, Isotretinoin was proven to inhibit the action of the metalloprotease <a href="/wiki/MMP-9" title="MMP-9" class="mw-redirect">MMP-9</a> (<a href="/wiki/Gelatinase" title="Gelatinase">gelatinase</a>) in <a href="/wiki/Sebum" title="Sebum" class="mw-redirect">sebum</a> without any influence in the action of <a href="/wiki/TIMP1" title="TIMP1">TIMP1</a> and <a href="/wiki/TIMP2" title="TIMP2">TIMP2</a> (the tissue inhibitors of metalloproteases).<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span>[</span>70<span>]</span></a></sup> It is already known that metalloproteases play an important role in the <a href="/wiki/Pathogenesis" title="Pathogenesis">pathogenesis</a> of acne.<sup id="cite_ref-pmid12102663_76-0" class="reference"><a href="#cite_note-pmid12102663-76"><span>[</span>71<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pharmacokinetics">Pharmacokinetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=11" title="Edit section: Pharmacokinetics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Oral Isotretinoin is best absorbed when taken with a high-fat meal, because it has a high level of <a href="/wiki/Lipophilicity" title="Lipophilicity">lipophilicity</a>.<sup id="cite_ref-drugs.com_77-0" class="reference"><a href="#cite_note-drugs.com-77"><span>[</span>72<span>]</span></a></sup> The efficacy of isotretinoin doubles when taken after a high-fat meal compared to when taken without food.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span>[</span>73<span>]</span></a></sup> Due to Isotretinoin's molecular relationship to Vitamin A, it should not be taken with Vitamin A supplements due to the danger of toxicity through cumulative overdosing.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span>[</span>74<span>]</span></a></sup> Accutane also negatively interacts with tetracycline, another class of acne drug, and with micro-dosed ('mini-pill') <a href="/wiki/Progesterone" title="Progesterone">progesterone</a> preparations, <a href="/wiki/Norethindrone" title="Norethindrone" class="mw-redirect">norethindrone</a>/ethinyl estradiol ('OrthoNovum 7/7/7'), <a href="/wiki/St._John%27s_Wort" title="St. John's Wort" class="mw-redirect">St. John's Wort</a>, <a href="/wiki/Phenytoin" title="Phenytoin">Phenytoin</a>, and systemic <a href="/wiki/Corticosteroid" title="Corticosteroid">corticosteroids</a>.</p>
<p>Isotretinoin is primarily (99.9%) bound to plasma proteins, mostly <a href="/wiki/Albumin" title="Albumin">albumin</a>. Three metabolites of Isotretinoin are detectable in human plasma after oral administration: 4-<i>oxo</i>-isotretinoin, retinoid acid (tretinoin), and 4-<i>oxo</i>-retinoic acid (4-<i>oxo</i>-tretinoin). Isotretinoin also oxidizes, irreversibly, to 4-<i>oxo</i>-isotretinoin—which forms its geometric isomer 4-<i>oxo</i>-tretinoin. After an orally-administered, 80&#160;mg dose of liquid suspension 14C-isotretinoin, 14C-activity in blood declines with a half-life of 90 hours.<sup id="cite_ref-drugs.com_77-1" class="reference"><a href="#cite_note-drugs.com-77"><span>[</span>72<span>]</span></a></sup> The metabolites of isotretinoin and its conjugates are then excreted in the subject's <a href="/wiki/Urine" title="Urine">urine</a> and <a href="/wiki/Faeces" title="Faeces" class="mw-redirect">faeces</a> in relatively equal amounts.<sup id="cite_ref-drugs.com_77-2" class="reference"><a href="#cite_note-drugs.com-77"><span>[</span>72<span>]</span></a></sup> After a single, 80&#160;mg oral dose of Isotretinoin to 74 healthy adult subjects under fed conditions, the mean ±SD <a href="/wiki/Biological_half-life" title="Biological half-life">elimination half-life</a> (t<sub>1/2</sub>) of isotretinoin and 4-<i>oxo</i>-isotretinoin were 21.0 ± 8.2 hours and 24.0 ± 5.3 hours, respectively.<sup id="cite_ref-drugs.com_77-3" class="reference"><a href="#cite_note-drugs.com-77"><span>[</span>72<span>]</span></a></sup> After both single and multiple doses, the observed accumulation ratios of isotretinoin ranged from 0.90 to 5.43 in patients with cystic acne.<sup id="cite_ref-drugs.com_77-4" class="reference"><a href="#cite_note-drugs.com-77"><span>[</span>72<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=12" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The compound 13-cis retinoic acid was first studied in the 1960s at Roche Laboratories in Switzerland by Werner Bollag as a treatment for skin cancer. Experiments completed in 1971 showed that the compound was likely to be ineffective for cancer and, surprisingly, that it could be useful to treat acne. They also showed that the compound was likely to cause birth defects, and in light of the events around <a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a> so Roche abandoned the product. In 1975, Gary Peck and Frank Yoder independently rediscovered the drug's use as a treatment of cystic acne while studying it as a treatment for <a href="/wiki/Lamellar_ichthyosis" title="Lamellar ichthyosis">lamellar ichthyosis</a>, and published that work. Roche resumed work on the drug, In clinical trials, subjects were carefully screened to avoid including women who were or might become pregnant. Roche's <a href="/wiki/New_Drug_Application" title="New Drug Application">New Drug Application</a> for isotretinoin for the treatment of acne included data showing that the drug caused birth defects in rabbits, and was explicit that the drug had not been tested on pregnant women. Roche asked for a <a href="/wiki/Pregnancy_category" title="Pregnancy category">pregnancy category</a> of C on the drug label, but the FDA required a category of X. But there were no explicit controls for pregnancy. The FDA approved the application in 1982. In European countries, where thalidomide had been approved and its use had caused birth defects, isotretinoin was either not approved or was approved only with strict controls to ensure that pregnant women didn't take it.<sup id="cite_ref-Green_80-0" class="reference"><a href="#cite_note-Green-80"><span>[</span>75<span>]</span></a></sup></p>
<p>Scientists involved in the clinical trials published articles warning of birth defects at the same time the drug was launched in the US, but nonetheless isotretinoin was taken up quickly and widely, both among dermatologists and general practitioners. Cases of birth defects showed up in the first year, leading the FDA to begin publishing case reports and to Roche sending warning letters to doctors and placing warning stickers on drug bottles, and including stronger warnings on the label. Lawsuits against Roche started to be filed. In 1983 the FDA's advisory committee was convened and recommended stronger measures, which the FDA took and were that time unprecedented: warning blood banks not to accept blood from people taking the drug, and adding a warning to the label advising women to start taking contraceptives a month before starting the drug. However use of the drug continued to grow, as did the number of babies born with birth defects. In 1985 the label was updated to include a <a href="/wiki/Boxed_warning" title="Boxed warning">boxed warning</a>. In early 1988 the FDA called for another advisory committee, and FDA employees prepared an internal memo estimating that around 1,000 babies had been born with birth defects due isotretinoin, that up to around 1,000 miscarriages had been caused, and that between 5,000 and 7,000 women had had abortions due to isotretinoin. The memo was leaked to the New York Times<sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span>[</span>76<span>]</span></a></sup> a few days before the meeting, leading to a storm of media attention. In the committee meeting, dermatologists and Roche each argued to keep the drug on the market but to increase education efforts; pediatricians and the CDC argued to withdraw the drug from the market. The committee recommended to restrict physicians who could prescribe the drug and to require a second opinion before it could be prescribed. The FDA, believing it did not have authority under the law to restrict who had the right to prescribe the drug, kept the drug on the market but took further unprecedented measures: it required to Roche to make warnings yet more visible and graphic, provide doctors with <a href="/wiki/Informed_consent" title="Informed consent">informed consent</a> forms to be used when prescribing the drug, and to conduct follow up studies to test whether the measures were reducing exposure of pregnant women to the drug. Roche implemented those measures, and offered to pay for contraception counseling and pregnancy testing for women prescribed the drug - the program was called the "Pregnancy Prevention Program". Results of the follow up study published in 1995, showing that about a quarter of one percent of women taking isotretinoin had become pregnant while taking the drug. However, sales of the drug continued to increase (rising 200% between 1992 and 1999), so the number of babies born with birth defects didn't decrease.<sup id="cite_ref-Green_80-1" class="reference"><a href="#cite_note-Green-80"><span>[</span>75<span>]</span></a></sup></p>
<p>A CDC report published in 2000<sup id="cite_ref-82" class="reference"><a href="#cite_note-82"><span>[</span>77<span>]</span></a></sup> showed problems with the Pregnancy Prevention Program and showed that the increase in prescriptions was from off-label use, and prompted Roche to revamp its program, renaming it the "Targeted Pregnancy Prevention Program" and adding label changes like requirements for two pregnancy tests, two kinds of contraception, and for doctors to provide pharmacists with prescriptions directly; providing additional educational materials, and providing free pregnancy tests. The FDA had another advisory meeting in late 2000 that again debated how to prevent pregnant women from being exposed to the drug; dermatologists testified about the remarkable efficacy of the drug, the psychological impact of acne, and demanded autonomy to prescribe the drug; others argued that the drug be withdrawn or much stricter measures be taken. In 2001 the FDA announced a new regulatory scheme called SMART (the System to Manage Accutane Related Teratogenicity) that required Roche to provide defined training materials to doctors, and for doctors to sign and return a letter to Roche acknowledging that they had reviewed the training materials, for Roche to then send stickers to doctors, which doctors would have to place on prescriptions they give patients after they have confirmed a negative pregnancy test; prescriptions could only be written for 30 days and could not be renewed, thus requiring a new pregnancy test for each prescription.<sup id="cite_ref-Green_80-2" class="reference"><a href="#cite_note-Green-80"><span>[</span>75<span>]</span></a></sup></p>
<p>In February 2002, Roche's patents for isotretinoin expired, and there are now many other companies selling cheaper generic versions of the drug. On June 29, 2009, <a href="/wiki/Roche_Pharmaceuticals" title="Roche Pharmaceuticals" class="mw-redirect">Roche Pharmaceuticals</a>, the original creator and distributor of isotretinoin, officially discontinued both the manufacture and distribution of their <b>Accutane</b> brand in the <a href="/wiki/United_States" title="United States">United States</a> due to what the company described as business reasons related to low market share (below 5%), coupled with the high cost of defending personal-injury lawsuits brought by some patients prescribed the drug. Generic isotretinoin will remain available in the United States through various manufacturers. Roche USA continues to defend Accutane and claims to have treated over 13 million patients since its introduction in 1982. F. Hoffmann-La Roche Ltd. apparently will continue to manufacture and distribute <b>Roaccutane</b> outside of the United States.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83"><span>[</span>78<span>]</span></a></sup></p>
<p>Among others, actor <a href="/wiki/James_Marshall_(actor)" title="James Marshall (actor)">James Marshall</a> sued Roche over allegedly Accutane-related disease that resulted in removal of his <a href="/wiki/Colon_(anatomy)" title="Colon (anatomy)" class="mw-redirect">colon</a>.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>79<span>]</span></a></sup> The jury, however, decided that James Marshall had a pre-existing bowel disease.<sup id="cite_ref-urlIts_Curtains_On_Actors_Accutane_Lawsuit_.7C_Pharmalot_85-0" class="reference"><a href="#cite_note-urlIts_Curtains_On_Actors_Accutane_Lawsuit_.7C_Pharmalot-85"><span>[</span>80<span>]</span></a></sup></p>
<p>Several trials over inflammatory bowel disease claims have been held in the United States thus far, with many of them resulting in multimillion dollar judgments against the makers of isotretinoin.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>81<span>]</span></a></sup> In 2009 Roche decided to pull Accutane off the market, stating at the time that the move was related to market pressures and the high cost of defending Accutane lawsuits.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>82<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=13" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Hypervitaminosis_A_syndrome" title="Hypervitaminosis A syndrome" class="mw-redirect">Hypervitaminosis A syndrome</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=14" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><span class="citation journal">Millsop JW, Heller MM, Eliason MJ, Murase JE (2013). "Dermatological medication effects on male fertility". <i>Dermatol Ther</i> <b>26</b> (4): 337–46. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fdth.12069">10.1111/dth.12069</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23914891">23914891</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Dermatological+medication+effects+on+male+fertility&amp;rft.aulast=Millsop+JW%2C+Heller+MM%2C+Eliason+MJ%2C+Murase+JE&amp;rft.au=Millsop+JW%2C+Heller+MM%2C+Eliason+MJ%2C+Murase+JE&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fdth.12069&amp;rft_id=info%3Apmid%2F23914891&amp;rft.issue=4&amp;rft.jtitle=Dermatol+Ther&amp;rft.pages=337-46&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.epuris.ca/">Epuris by Cipher Pharmaceuticals</a></span></li>
<li id="cite_note-pmid19588674-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19588674_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Merritt B, Burkhart CN, Morrell DS (June 2009). "Use of isotretinoin for acne vulgaris". <i>Pediatr Ann</i> <b>38</b> (6): 311–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3928%2F00904481-20090512-01">10.3928/00904481-20090512-01</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19588674">19588674</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Use+of+isotretinoin+for+acne+vulgaris&amp;rft.aulast=Merritt+B%2C+Burkhart+CN%2C+Morrell+DS&amp;rft.au=Merritt+B%2C+Burkhart+CN%2C+Morrell+DS&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3928%2F00904481-20090512-01&amp;rft_id=info%3Apmid%2F19588674&amp;rft.issue=6&amp;rft.jtitle=Pediatr+Ann&amp;rft.pages=311-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20436884-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20436884_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20436884_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Layton A (May 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909">"The use of isotretinoin in acne"</a>. <i>Dermatoendocrinol</i> <b>1</b> (3): 162–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4161%2Fderm.1.3.9364">10.4161/derm.1.3.9364</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909">2835909</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20436884">20436884</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=The+use+of+isotretinoin+in+acne&amp;rft.aulast=Layton+A&amp;rft.au=Layton+A&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2835909&amp;rft_id=info%3Adoi%2F10.4161%2Fderm.1.3.9364&amp;rft_id=info%3Apmc%2F2835909&amp;rft_id=info%3Apmid%2F20436884&amp;rft.issue=3&amp;rft.jtitle=Dermatoendocrinol&amp;rft.pages=162-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AMH2006-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-AMH2006_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AMH2006_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Rossi S (2006). <i>Australian medicines handbook 2006</i>. Adelaide, S. Aust: Australian Medicines Handbook Pty Ltd. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-9757919-2-3" title="Special:BookSources/0-9757919-2-3">0-9757919-2-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.aulast=Rossi+S&amp;rft.au=Rossi+S&amp;rft.btitle=Australian+medicines+handbook+2006&amp;rft.date=2006&amp;rft.genre=book&amp;rft.isbn=0-9757919-2-3&amp;rft.place=Adelaide%2C+S.+Aust&amp;rft.pub=Australian+Medicines+Handbook+Pty+Ltd&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (October 2010)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-Micromedex-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Micromedex_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Micromedex_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Micromedex_10-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Micromedex_10-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Klasco RK, editor. Drugdex system, vol. 128. Greenwood Village (CO): Thomson Micromedex; 2006.<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (May 2012)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-pmid17276540-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17276540_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R (April 2007). "Guidelines of care for acne vulgaris management". <i>J. Am. Acad. Dermatol.</i> <b>56</b> (4): 651–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jaad.2006.08.048">10.1016/j.jaad.2006.08.048</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17276540">17276540</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Guidelines+of+care+for+acne+vulgaris+management&amp;rft.aulast=Strauss+JS%2C+Krowchuk+DP%2C+Leyden+JJ%2C+Lucky+AW%2C+Shalita+AR%2C+Siegfried+EC%2C+Thiboutot+DM%2C+Van+Voorhees+AS%2C+Beutner+KA%2C+Sieck+CK%2C+Bhushan+R&amp;rft.au=Strauss+JS%2C+Krowchuk+DP%2C+Leyden+JJ%2C+Lucky+AW%2C+Shalita+AR%2C+Siegfried+EC%2C+Thiboutot+DM%2C+Van+Voorhees+AS%2C+Beutner+KA%2C+Sieck+CK%2C+Bhushan+R&amp;rft.date=April+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2006.08.048&amp;rft_id=info%3Apmid%2F17276540&amp;rft.issue=4&amp;rft.jtitle=J.+Am.+Acad.+Dermatol.&amp;rft.pages=651-63&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=56" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Oral_isotretinoin_Therapy-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Oral_isotretinoin_Therapy_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (June 2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851">"Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial"</a>. <i>Sex Transm Infect</i> <b>80</b> (3): 216–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fsti.2003.006841">10.1136/sti.2003.006841</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851">1744851</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15170007">15170007</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Oral+isotretinoin+in+the+treatment+of+recalcitrant+condylomata+acuminata+of+the+cervix%3A+a+randomised+placebo+controlled+trial&amp;rft.au=Georgala+S%2C+Katoulis+AC%2C+Georgala+C%2C+Bozi+E%2C+Mortakis+A&amp;rft.aulast=Georgala+S%2C+Katoulis+AC%2C+Georgala+C%2C+Bozi+E%2C+Mortakis+A&amp;rft.date=June+2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1744851&amp;rft_id=info%3Adoi%2F10.1136%2Fsti.2003.006841&amp;rft_id=info%3Apmc%2F1744851&amp;rft_id=info%3Apmid%2F15170007&amp;rft.issue=3&amp;rft.jtitle=Sex+Transm+Infect&amp;rft.pages=216-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=80" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Unapproved_Isotretinoin-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Unapproved_Isotretinoin_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sehgal VN, Srivastava G, Sardana K (June 2006). "Isotretinoin--unapproved indications/uses and dosage: a physician's reference". <i>Int. J. Dermatol.</i> <b>45</b> (6): 772–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-4632.2006.02830.x">10.1111/j.1365-4632.2006.02830.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16796650">16796650</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin--unapproved+indications%2Fuses+and+dosage%3A+a+physician%27s+reference&amp;rft.aulast=Sehgal+VN%2C+Srivastava+G%2C+Sardana+K&amp;rft.au=Sehgal+VN%2C+Srivastava+G%2C+Sardana+K&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-4632.2006.02830.x&amp;rft_id=info%3Apmid%2F16796650&amp;rft.issue=6&amp;rft.jtitle=Int.+J.+Dermatol.&amp;rft.pages=772-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Choi2013-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Choi2013_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Choi2013_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Choi JS, Koren G, Nulman I. Pregnancy and isotretinoin therapy. CMAJ. 2013 Mar 19;185(5):411-3. doi: 10.1503/cmaj.120729. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/23296582?dopt=Abstract">PMID 23296582</a>. <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257/">PMC 3602257</a></span></li>
<li id="cite_note-BNF47-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-BNF47_15-0">^</a></b></span> <span class="reference-text">Joint Formulary Committee. <a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a>. 47th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain. <a href="/wiki/Special:BookSources/0853695849" class="internal mw-magiclink-isbn">ISBN 0-85369-584-9</a><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (May 2012)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal"><a rel="nofollow" class="external text" href="http://www.australiandoctor.com.au/news/latest-news/fresh-call-for-gps-to-prescribe-roaccutane">"Fresh call for GPs to prescribe Roaccutane"</a>. <i>AustralianDoctor</i>. 19 June 2012.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Fresh+call+for+GPs+to+prescribe+Roaccutane&amp;rft.date=19+June+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.australiandoctor.com.au%2Fnews%2Flatest-news%2Ffresh-call-for-gps-to-prescribe-roaccutane&amp;rft.jtitle=AustralianDoctor&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text">Specifically, doctors who are fellows of the Australasian College of Dermatologists (FACD); cf. Pharmaceutical Services Branch, <i>Guide to poisons and therapeutic goods legislation for medical practitioners and dentists</i>, Sydney: NSW Department of Health; 2006.<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (October 2010)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-James_1996-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-James_1996_18-0">^</a></b></span> <span class="reference-text"><span class="citation journal">James M (June 1996). "Isotretinoin for severe acne". <i>Lancet</i> <b>347</b> (9017): 1749–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2896%2990814-4">10.1016/S0140-6736(96)90814-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8656912">8656912</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+for+severe+acne&amp;rft.au=James+M&amp;rft.aulast=James+M&amp;rft.date=June+1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2896%2990814-4&amp;rft_id=info%3Apmid%2F8656912&amp;rft.issue=9017&amp;rft.jtitle=Lancet&amp;rft.pages=1749-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=347" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.medsafe.govt.nz/profs/puarticles/isotretdtb.htm">"Acne, Isotretinoin, and Depression"</a>. MEDSAFE (New Zealand Ministry of Health). June 2013 [June 2005]<span class="reference-accessdate">. Retrieved <span class="nowrap">7 February</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=Acne%2C+Isotretinoin%2C+and+Depression&amp;rft.date=June+2013&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.medsafe.govt.nz%2Fprofs%2Fpuarticles%2Fisotretdtb.htm&amp;rft.pub=MEDSAFE+%28New+Zealand+Ministry+of+Health%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="https://www.ipledgeprogram.com/AboutiPLEDGE.aspx">"iPledge (About iPledge)"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=iPledge+%28About+iPledge%29&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fwww.ipledgeprogram.com%2FAboutiPLEDGE.aspx&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094305.htm">"Isotretinoin (marketed as Accutane) Capsule Information"</a>. U.S. Food and Drug Administration (FDA).</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=Isotretinoin+%28marketed+as+Accutane%29+Capsule+Information&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2FPostmarketDrugSafetyInformationforPatientsandProviders%2Fucm094305.htm&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text">United States Pharmacopeia Staff. Consumer Reports Complete Drug Reference. Yonkers, NY: Consumer Reports Books, 1995. Pg 998.</span></li>
<li id="cite_note-Amichai_2006-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amichai_2006_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Amichai B, Shemer A, Grunwald MH (April 2006). "Low-dose isotretinoin in the treatment of acne vulgaris". <i>J. Am. Acad. Dermatol.</i> <b>54</b> (4): 644–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jaad.2005.11.1061">10.1016/j.jaad.2005.11.1061</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16546586">16546586</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Low-dose+isotretinoin+in+the+treatment+of+acne+vulgaris&amp;rft.au=Amichai+B%2C+Shemer+A%2C+Grunwald+MH&amp;rft.aulast=Amichai+B%2C+Shemer+A%2C+Grunwald+MH&amp;rft.date=April+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2005.11.1061&amp;rft_id=info%3Apmid%2F16546586&amp;rft.issue=4&amp;rft.jtitle=J.+Am.+Acad.+Dermatol.&amp;rft.pages=644-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Seukeran_1998-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Seukeran_1998_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Seukeran DC, Cunliffe WJ (July 1998). "Acne vulgaris in the elderly: the response to low-dose isotretinoin". <i>Br. J. Dermatol.</i> <b>139</b> (1): 99–101. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1365-2133.1998.02321.x">10.1046/j.1365-2133.1998.02321.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9764156">9764156</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Acne+vulgaris+in+the+elderly%3A+the+response+to+low-dose+isotretinoin&amp;rft.aulast=Seukeran+DC%2C+Cunliffe+WJ&amp;rft.au=Seukeran+DC%2C+Cunliffe+WJ&amp;rft.date=July+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2133.1998.02321.x&amp;rft_id=info%3Apmid%2F9764156&amp;rft.issue=1&amp;rft.jtitle=Br.+J.+Dermatol.&amp;rft.pages=99-101&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=139" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8112947-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8112947_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Shahidullah M, Tham SN, Goh CL (January 1994). "Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore". <i>Int. J. Dermatol.</i> <b>33</b> (1): 60–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-4362.1994.tb01500.x">10.1111/j.1365-4362.1994.tb01500.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8112947">8112947</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+therapy+in+acne+vulgaris%3A+a+10-year+retrospective+study+in+Singapore&amp;rft.aulast=Shahidullah+M%2C+Tham+SN%2C+Goh+CL&amp;rft.au=Shahidullah+M%2C+Tham+SN%2C+Goh+CL&amp;rft.date=January+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-4362.1994.tb01500.x&amp;rft_id=info%3Apmid%2F8112947&amp;rft.issue=1&amp;rft.jtitle=Int.+J.+Dermatol.&amp;rft.pages=60-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9784036-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9784036_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hermes B, Praetel C, Henz BM (September 1998). "Medium dose isotretinoin for the treatment of acne". <i>J Eur Acad Dermatol Venereol</i> <b>11</b> (2): 117–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1468-3083.1998.tb00763.x">10.1111/j.1468-3083.1998.tb00763.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9784036">9784036</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Medium+dose+isotretinoin+for+the+treatment+of+acne&amp;rft.au=Hermes+B%2C+Praetel+C%2C+Henz+BM&amp;rft.aulast=Hermes+B%2C+Praetel+C%2C+Henz+BM&amp;rft.date=September+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1468-3083.1998.tb00763.x&amp;rft_id=info%3Apmid%2F9784036&amp;rft.issue=2&amp;rft.jtitle=J+Eur+Acad+Dermatol+Venereol&amp;rft.pages=117-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9933749-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9933749_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lin J, Shih I, Yu C (February 1999). "Hemodialysis-related nodulocystic acne treated with isotretinoin". <i>Nephron</i> <b>81</b> (2): 146–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000045270">10.1159/000045270</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9933749">9933749</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Hemodialysis-related+nodulocystic+acne+treated+with+isotretinoin&amp;rft.aulast=Lin+J%2C+Shih+I%2C+Yu+C&amp;rft.au=Lin+J%2C+Shih+I%2C+Yu+C&amp;rft.date=February+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000045270&amp;rft_id=info%3Apmid%2F9933749&amp;rft.issue=2&amp;rft.jtitle=Nephron&amp;rft.pages=146-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=81" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8129410-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8129410_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ertl GA, Levine N, Kligman AM (March 1994). "A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea". <i>Arch Dermatol</i> <b>130</b> (3): 319–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchderm.130.3.319">10.1001/archderm.130.3.319</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8129410">8129410</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=A+comparison+of+the+efficacy+of+topical+tretinoin+and+low-dose+oral+isotretinoin+in+rosacea&amp;rft.au=Ertl+GA%2C+Levine+N%2C+Kligman+AM&amp;rft.aulast=Ertl+GA%2C+Levine+N%2C+Kligman+AM&amp;rft.date=March+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchderm.130.3.319&amp;rft_id=info%3Apmid%2F8129410&amp;rft.issue=3&amp;rft.jtitle=Arch+Dermatol&amp;rft.pages=319-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=130" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Connie L. Barnes, Angie L. Osborne. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071225182847/http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/apr00iso.cfm&amp;pub_id=8&amp;article_id=508">"Isotretinoin Uses and Effects"</a>. <i>U.S. Pharmacist</i>. Archived from <a rel="nofollow" class="external text" href="http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/apr00iso.cfm&amp;pub_id=8&amp;article_id=508">the original</a> on 2007-12-25.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+Uses+and+Effects&amp;rft.au=Connie+L.+Barnes%2C+Angie+L.+Osborne&amp;rft.aulast=Connie+L.+Barnes%2C+Angie+L.+Osborne&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.uspharmacist.com%2Foldformat.asp%3Furl%3Dnewlook%2Ffiles%2FFeat%2Fapr00iso.cfm%26pub_id%3D8%26article_id%3D508&amp;rft.jtitle=U.S.+Pharmacist&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-James2005-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-James2005_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">James WD (April 2005). "Clinical practice. Acne". <i>N. Engl. J. Med.</i> <b>352</b> (14): 1463–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMcp033487">10.1056/NEJMcp033487</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15814882">15814882</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Clinical+practice.+Acne&amp;rft.au=James+WD&amp;rft.aulast=James+WD&amp;rft.date=April+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMcp033487&amp;rft_id=info%3Apmid%2F15814882&amp;rft.issue=14&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1463-72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=352" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16484812-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16484812_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zouboulis CC (2006). "The truth behind this undeniable efficacy--recurrence rates and relapse risk factors of acne treatment with oral isotretinoin". <i>Dermatology (Basel)</i> <b>212</b> (2): 99–100. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000090646">10.1159/000090646</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16484812">16484812</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=The+truth+behind+this+undeniable+efficacy--recurrence+rates+and+relapse+risk+factors+of+acne+treatment+with+oral+isotretinoin&amp;rft.aulast=Zouboulis+CC&amp;rft.au=Zouboulis+CC&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000090646&amp;rft_id=info%3Apmid%2F16484812&amp;rft.issue=2&amp;rft.jtitle=Dermatology+%28Basel%29&amp;rft.pages=99-100&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=212" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16409263-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16409263_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Haryati I, Jacinto SS (December 2005). "Profile of acne patients in the Philippines requiring a second course of oral isotretinoin". <i>Int. J. Dermatol.</i> <b>44</b> (12): 999–1001. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-4632.2005.02284.x">10.1111/j.1365-4632.2005.02284.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16409263">16409263</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Profile+of+acne+patients+in+the+Philippines+requiring+a+second+course+of+oral+isotretinoin&amp;rft.au=Haryati+I%2C+Jacinto+SS&amp;rft.aulast=Haryati+I%2C+Jacinto+SS&amp;rft.date=December+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-4632.2005.02284.x&amp;rft_id=info%3Apmid%2F16409263&amp;rft.issue=12&amp;rft.jtitle=Int.+J.+Dermatol.&amp;rft.pages=999-1001&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17970803-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17970803_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Azoulay L, Oraichi D, Bérard A (December 2007). "Isotretinoin therapy and the incidence of acne relapse: a nested case-control study". <i>Br. J. Dermatol.</i> <b>157</b> (6): 1240–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2133.2007.08250.x">10.1111/j.1365-2133.2007.08250.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17970803">17970803</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+therapy+and+the+incidence+of+acne+relapse%3A+a+nested+case-control+study&amp;rft.au=Azoulay+L%2C+Oraichi+D%2C+B%C3%A9rard+A&amp;rft.aulast=Azoulay+L%2C+Oraichi+D%2C+B%C3%A9rard+A&amp;rft.date=December+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2007.08250.x&amp;rft_id=info%3Apmid%2F17970803&amp;rft.issue=6&amp;rft.jtitle=Br.+J.+Dermatol.&amp;rft.pages=1240-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=157" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19067687-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19067687_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Layton AM, Dréno B, Gollnick H, Mobaken H, Shear N (January 2009). "Isotretinoin therapy and the incidence of acne relapse: a nested case-control study". <i>Br. J. Dermatol.</i> <b>160</b> (1): 217–8; author reply 218–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2133.2008.08935.x">10.1111/j.1365-2133.2008.08935.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19067687">19067687</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+therapy+and+the+incidence+of+acne+relapse%3A+a+nested+case-control+study&amp;rft.aulast=Layton+AM%2C+Dr%C3%A9no+B%2C+Gollnick+H%2C+Mobaken+H%2C+Shear+N&amp;rft.au=Layton+AM%2C+Dr%C3%A9no+B%2C+Gollnick+H%2C+Mobaken+H%2C+Shear+N&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2008.08935.x&amp;rft_id=info%3Apmid%2F19067687&amp;rft.issue=1&amp;rft.jtitle=Br.+J.+Dermatol.&amp;rft.pages=217-8%3B+author+reply+218-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=160" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.netdoctor.co.uk/skin-and-hair/medicines/roaccutane.html">NetDoctor.co.uk / Roaccutane</a></span></li>
<li id="cite_note-urlIsotretinoin_20mg_capsules_-_Summary_of_Product_Characteristics_.28SPC.29_-_.28eMC.29-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlIsotretinoin_20mg_capsules_-_Summary_of_Product_Characteristics_.28SPC.29_-_.28eMC.29_36-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.medicines.org.uk/emc/medicine/15655/spc">"Isotretinoin 20 mg capsules, Summary of Product Characteristics"</a>. <i>electronic Medicines Compendium (eMC)</i>. Datapharm Communications Ltd.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+20+mg+capsules%2C++Summary+of+Product+Characteristics&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fmedicine%2F15655%2Fspc&amp;rft.jtitle=electronic+Medicines+Compendium+%28eMC%29&amp;rft.pub=Datapharm+Communications+Ltd&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9093712-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9093712_37-0">^</a></b></span> <span class="reference-text"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (August 2013)">unreliable medical source?</span></a></i>]</sup><span class="citation journal">Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, Fritsche HA, Lippman SM (January 1997). <a rel="nofollow" class="external text" href="http://annonc.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=9093712">"Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity"</a>. <i>Ann. Oncol.</i> <b>8</b> (1): 85–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1023%2FA%3A1008209525671">10.1023/A:1008209525671</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9093712">9093712</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Phase+I+trial+of+alpha-tocopherol+effects+on+13-cis-retinoic+acid+toxicity&amp;rft.au=Dimery+IW%2C+Hong+WK%2C+Lee+JJ%2C+Guillory-Perez+C%2C+Pham+F%2C+Fritsche+HA%2C+Lippman+SM&amp;rft.aulast=Dimery+IW%2C+Hong+WK%2C+Lee+JJ%2C+Guillory-Perez+C%2C+Pham+F%2C+Fritsche+HA%2C+Lippman+SM&amp;rft.date=January+1997&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fannonc.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9093712&amp;rft_id=info%3Adoi%2F10.1023%2FA%3A1008209525671&amp;rft_id=info%3Apmid%2F9093712&amp;rft.issue=1&amp;rft.jtitle=Ann.+Oncol.&amp;rft.pages=85-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2252043-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2252043_38-0">^</a></b></span> <span class="reference-text"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (August 2013)">unreliable medical source?</span></a></i>]</sup><span class="citation journal">Besa EC, Abrahm JL, Bartholomew MJ, Hyzinski M, Nowell PC (December 1990). "Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol". <i>Am. J. Med.</i> <b>89</b> (6): 739–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0002-9343%2890%2990215-Y">10.1016/0002-9343(90)90215-Y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2252043">2252043</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Treatment+with+13-cis-retinoic+acid+in+transfusion-dependent+patients+with+myelodysplastic+syndrome+and+decreased+toxicity+with+addition+of+alpha-tocopherol&amp;rft.au=Besa+EC%2C+Abrahm+JL%2C+Bartholomew+MJ%2C+Hyzinski+M%2C+Nowell+PC&amp;rft.aulast=Besa+EC%2C+Abrahm+JL%2C+Bartholomew+MJ%2C+Hyzinski+M%2C+Nowell+PC&amp;rft.date=December+1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0002-9343%2890%2990215-Y&amp;rft_id=info%3Apmid%2F2252043&amp;rft.issue=6&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=739-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kus_2005-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kus_2005_39-0">^</a></b></span> <span class="reference-text"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (August 2013)">unreliable medical source?</span></a></i>]</sup><span class="citation journal">Kus S, Gün D, Demirçay Z, Sur H (March 2005). "Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris". <i>Int. J. Dermatol.</i> <b>44</b> (3): 248–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-4632.2004.02072.x">10.1111/j.1365-4632.2004.02072.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15807739">15807739</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Vitamin+E+does+not+reduce+the+side-effects+of+isotretinoin+in+the+treatment+of+acne+vulgaris&amp;rft.au=Kus+S%2C+G%C3%BCn+D%2C+Demir%C3%A7ay+Z%2C+Sur+H&amp;rft.aulast=Kus+S%2C+G%C3%BCn+D%2C+Demir%C3%A7ay+Z%2C+Sur+H&amp;rft.date=March+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-4632.2004.02072.x&amp;rft_id=info%3Apmid%2F15807739&amp;rft.issue=3&amp;rft.jtitle=Int.+J.+Dermatol.&amp;rft.pages=248-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><span class="citation report"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s060lbl.pdf">(Label)</a> <span style="font-size:85%;">(PDF)</span>. <i>Drugs@FDA</i> (Report) (Roche Laboratories). January 2010: 41. NDA 018662/S-060<span class="reference-accessdate">. Retrieved <span class="nowrap">3 August</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=%28Label%29&amp;rft.date=January+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F018662s060lbl.pdf&amp;rft.jtitle=Drugs%40FDA&amp;rft.pages=41&amp;rft.pub=Roche+Laboratories&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation journal">Lawson JP, McGuire J (1987). "The spectrum of skeletal changes associated with long-term administration of 13-cis-retinoic acid". <i>Skeletal Radiology</i> <b>16</b> (2): 91–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2FBF00367754">10.1007/BF00367754</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3107131">3107131</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=The+spectrum+of+skeletal+changes+associated+with+long-term+administration+of+13-cis-retinoic+acid&amp;rft.aulast=Lawson+JP%2C+McGuire+J&amp;rft.au=Lawson+JP%2C+McGuire+J&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF00367754&amp;rft_id=info%3Apmid%2F3107131&amp;rft.issue=2&amp;rft.jtitle=Skeletal+Radiology&amp;rft.pages=91-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><span class="citation journal">David M, Hodak E, Lowe NJ (1988). "Adverse effects of retinoids". <i>Medical toxicology and adverse drug experience</i> <b>3</b> (4): 273–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fbf03259940">10.1007/bf03259940</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3054426">3054426</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Adverse+effects+of+retinoids&amp;rft.au=David+M%2C+Hodak+E%2C+Lowe+NJ&amp;rft.aulast=David+M%2C+Hodak+E%2C+Lowe+NJ&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fbf03259940&amp;rft_id=info%3Apmid%2F3054426&amp;rft.issue=4&amp;rft.jtitle=Medical+toxicology+and+adverse+drug+experience&amp;rft.pages=273-88&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><span class="citation journal">Orfanos CE (1989). "Retinoide: der neue Stand. Erhaltungstherapie, Resorptionsstörungen bei 'non-responders', Interaktionen und Interferenzen mit Medikamenten, Behandlung von Kindern und Knochentoxizität, Acitretin und 13-cis-Acitretin" [Retinoids: the new status. Maintenance therapy, disorders of resorption in 'non-responders', interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin]. <i>Hautarzt</i> (in German) <b>40</b> (3): 123–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2523875">2523875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Retinoide%3A+der+neue+Stand.+Erhaltungstherapie%2C+Resorptionsst%C3%B6rungen+bei+%27non-responders%27%2C+Interaktionen+und+Interferenzen+mit+Medikamenten%2C+Behandlung+von+Kindern+und+Knochentoxizit%C3%A4t%2C+Acitretin+und+13-cis-Acitretin&amp;rft.aulast=Orfanos+CE&amp;rft.au=Orfanos+CE&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2523875&amp;rft.issue=3&amp;rft.jtitle=Hautarzt&amp;rft.pages=123-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><span class="citation journal">DiGiovanna JJ (2001). "Isotretinoin effects on bone". <i>Journal of the American Academy of Dermatology</i> <b>45</b> (5): S176–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1067%2Fmjd.2001.113721">10.1067/mjd.2001.113721</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11606950">11606950</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+effects+on+bone&amp;rft.au=DiGiovanna+JJ&amp;rft.aulast=DiGiovanna+JJ&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1067%2Fmjd.2001.113721&amp;rft_id=info%3Apmid%2F11606950&amp;rft.issue=5&amp;rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&amp;rft.pages=S176-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20354506-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20354506_46-0">^</a></b></span> <span class="reference-text"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (August 2013)">unreliable medical source?</span></a></i>]</sup><span class="citation journal">Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD (September 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620">"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study"</a>. <i>Am. J. Gastroenterol.</i> <b>105</b> (9): 1986–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fajg.2010.124">10.1038/ajg.2010.124</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620">3073620</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20354506">20354506</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+use+and+the+risk+of+inflammatory+bowel+disease%3A+a+case-control+study&amp;rft.au=Crockett+SD%2C+Porter+CQ%2C+Martin+CF%2C+Sandler+RS%2C+Kappelman+MD&amp;rft.aulast=Crockett+SD%2C+Porter+CQ%2C+Martin+CF%2C+Sandler+RS%2C+Kappelman+MD&amp;rft.date=September+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3073620&amp;rft_id=info%3Adoi%2F10.1038%2Fajg.2010.124&amp;rft_id=info%3Apmc%2F3073620&amp;rft_id=info%3Apmid%2F20354506&amp;rft.issue=9&amp;rft.jtitle=Am.+J.+Gastroenterol.&amp;rft.pages=1986-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=105" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid23426479-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23426479_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Etminan M, Bird ST, Delaney JA, Bressler B, Brophy JM (February 2013). "Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data". <i>JAMA Dermatol</i> <b>149</b> (2): 216–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjamadermatol.2013.1344">10.1001/jamadermatol.2013.1344</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23426479">23426479</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+and+risk+for+inflammatory+bowel+disease%3A+a+nested+case-control+study+and+meta-analysis+of+published+and+unpublished+data&amp;rft.au=Etminan+M%2C+Bird+ST%2C+Delaney+JA%2C+Bressler+B%2C+Brophy+JM&amp;rft.aulast=Etminan+M%2C+Bird+ST%2C+Delaney+JA%2C+Bressler+B%2C+Brophy+JM&amp;rft.date=February+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjamadermatol.2013.1344&amp;rft_id=info%3Apmid%2F23426479&amp;rft.issue=2&amp;rft.jtitle=JAMA+Dermatol&amp;rft.pages=216-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=149" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Mollan SP, Woodcock M, Siddiqi R, Huntbach J, Good P, Scott RA (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1857209">"Does use of isotretinoin rule out a career in flying?"</a>. <i>The British journal of ophthalmology</i> <b>90</b> (8): 957–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbjo.2006.092833">10.1136/bjo.2006.092833</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1857209">1857209</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16723361">16723361</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Does+use+of+isotretinoin+rule+out+a+career+in+flying%3F&amp;rft.aulast=Mollan+SP%2C+Woodcock+M%2C+Siddiqi+R%2C+Huntbach+J%2C+Good+P%2C+Scott+RA&amp;rft.au=Mollan+SP%2C+Woodcock+M%2C+Siddiqi+R%2C+Huntbach+J%2C+Good+P%2C+Scott+RA&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1857209&amp;rft_id=info%3Adoi%2F10.1136%2Fbjo.2006.092833&amp;rft_id=info%3Apmc%2F1857209&amp;rft_id=info%3Apmid%2F16723361&amp;rft.issue=8&amp;rft.jtitle=The+British+journal+of+ophthalmology&amp;rft.pages=957-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-autogenerated299-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-autogenerated299_49-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fraunfelder FT, Fraunfelder FW, Edwards R (2001). "Ocular side effects possibly associated with isotretinoin usage". <i>American journal of ophthalmology</i> <b>132</b> (3): 299–305. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0002-9394%2801%2901024-8">10.1016/S0002-9394(01)01024-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11530040">11530040</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Ocular+side+effects+possibly+associated+with+isotretinoin+usage&amp;rft.au=Fraunfelder+FT%2C+Fraunfelder+FW%2C+Edwards+R&amp;rft.aulast=Fraunfelder+FT%2C+Fraunfelder+FW%2C+Edwards+R&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0002-9394%2801%2901024-8&amp;rft_id=info%3Apmid%2F11530040&amp;rft.issue=3&amp;rft.jtitle=American+journal+of+ophthalmology&amp;rft.pages=299-305&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=132" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><span class="citation journal">Pittsley RA, Yoder FW (1983). "Retinoid Hyperostosis". <i>New England Journal of Medicine</i> <b>308</b> (17): 1012–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM198304283081707">10.1056/NEJM198304283081707</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6403861">6403861</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Retinoid+Hyperostosis&amp;rft.aulast=Pittsley+RA%2C+Yoder+FW&amp;rft.au=Pittsley+RA%2C+Yoder+FW&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM198304283081707&amp;rft_id=info%3Apmid%2F6403861&amp;rft.issue=17&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=1012-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=308" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Tangrea JA, Kilcoyne RF, Taylor PR, Helsel WE, Adrianza ME, Hartman AM, Edwards BK, Peck GL (1992). "Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin". <i>Archives of dermatology</i> <b>128</b> (7): 921–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchderm.1992.01680170053004">10.1001/archderm.1992.01680170053004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1626958">1626958</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Skeletal+hyperostosis+in+patients+receiving+chronic%2C+very-low-dose+isotretinoin&amp;rft.aulast=Tangrea+JA%2C+Kilcoyne+RF%2C+Taylor+PR%2C+Helsel+WE%2C+Adrianza+ME%2C+Hartman+AM%2C+Edwards+BK%2C+Peck+GL&amp;rft.au=Tangrea+JA%2C+Kilcoyne+RF%2C+Taylor+PR%2C+Helsel+WE%2C+Adrianza+ME%2C+Hartman+AM%2C+Edwards+BK%2C+Peck+GL&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchderm.1992.01680170053004&amp;rft_id=info%3Apmid%2F1626958&amp;rft.issue=7&amp;rft.jtitle=Archives+of+dermatology&amp;rft.pages=921-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=128" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16703787-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16703787_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Scheinfeld N, Bangalore S (May 2006). "Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin". <i>J Drugs Dermatol</i> <b>5</b> (5): 467–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16703787">16703787</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Facial+edema+induced+by+isotretinoin+use%3A+a+case+and+a+review+of+the+side+effects+of+isotretinoin&amp;rft.aulast=Scheinfeld+N%2C+Bangalore+S&amp;rft.au=Scheinfeld+N%2C+Bangalore+S&amp;rft.date=May+2006&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F16703787&amp;rft.issue=5&amp;rft.jtitle=J+Drugs+Dermatol&amp;rft.pages=467-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RoaccutanePI-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-RoaccutanePI_53-0">^</a></b></span> <span class="reference-text">Roche Products Pty Ltd. Roaccutane (Australian Approved Product Information). Dee Why (NSW): Roche; 2005.<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (October 2010)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation journal">Leyden JJ, Del Rosso JQ, Baum EW (February 2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835">"The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions"</a>. <i>J Clin Aesthet Dermatol</i> <b>7</b> (2 Suppl): S3–S21. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835">3970835</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24688620">24688620</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=The+use+of+isotretinoin+in+the+treatment+of+acne+vulgaris%3A+clinical+considerations+and+future+directions&amp;rft.aulast=Leyden+JJ%2C+Del+Rosso+JQ%2C+Baum+EW&amp;rft.au=Leyden+JJ%2C+Del+Rosso+JQ%2C+Baum+EW&amp;rft.date=February+2014&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3970835&amp;rft_id=info%3Apmc%2F3970835&amp;rft_id=info%3Apmid%2F24688620&amp;rft.issue=2+Suppl&amp;rft.jtitle=J+Clin+Aesthet+Dermatol&amp;rft.pages=S3-S21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text">BNF, edition 57<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (October 2010)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-bjd2010-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-bjd2010_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bjd2010_56-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-bjd2010_56-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD (2010). <a rel="nofollow" class="external text" href="http://www.bad.org.uk/Portals/_Bad/Guidelines/Clinical%20Guidelines/Isotretinoin%20Guidelines%202010.pdf">"Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010"</a> <span style="font-size:85%;">(PDF)</span>. <i>British Journal of Dermatology</i> <b>162</b> (6): 1172–1179. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2133.2010.09836.x">10.1111/j.1365-2133.2010.09836.x</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0007-0963">0007-0963</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21250961">21250961</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Advice+on+the+safe+introduction+and+continued+use+of+isotretinoin+in+acne+in+the+U.K.+2010&amp;rft.au=Goodfield+MJ%2C+Cox+NH%2C+Bowser+A%2C+McMillan+JC%2C+Millard+LG%2C+Simpson+NB%2C+Ormerod+AD&amp;rft.aulast=Goodfield+MJ%2C+Cox+NH%2C+Bowser+A%2C+McMillan+JC%2C+Millard+LG%2C+Simpson+NB%2C+Ormerod+AD&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bad.org.uk%2FPortals%2F_Bad%2FGuidelines%2FClinical%2520Guidelines%2FIsotretinoin%2520Guidelines%25202010.pdf&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2010.09836.x&amp;rft_id=info%3Apmid%2F21250961&amp;rft.issn=00070963&amp;rft.issue=6&amp;rft.jtitle=British+Journal+of+Dermatology&amp;rft.pages=1172-1179&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=162" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-dreno2008-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-dreno2008_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-dreno2008_57-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dreno, B; Chosidow, O (2008). "Isotretinoin and psychiatric side effects: facts and hypothesis". <i>Expert Review of Dermatology</i> <b>3</b> (6): 711–720. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1586%2F17469872.3.6.711">10.1586/17469872.3.6.711</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1746-9872">1746-9872</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+and+psychiatric+side+effects%3A+facts+and+hypothesis&amp;rft.au=Chosidow%2C+O&amp;rft.au=Dreno%2C+B&amp;rft.aufirst=B&amp;rft.aulast=Dreno&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1586%2F17469872.3.6.711&amp;rft.issn=1746-9872&amp;rft.issue=6&amp;rft.jtitle=Expert+Review+of+Dermatology&amp;rft.pages=711-720&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-kontaxakis2009-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-kontaxakis2009_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-kontaxakis2009_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN (2009). <a rel="nofollow" class="external text" href="http://www.annals-general-psychiatry.com/content/8/1/2">"Isotretinoin and psychopathology: a review"</a>. <i>Annals of General Psychiatry</i> <b>8</b> (1): 2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1744-859X-8-2">10.1186/1744-859X-8-2</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1744-859X">1744-859X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19154613">19154613</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin+and+psychopathology%3A+a+review&amp;rft.au=Kontaxakis+VP%2C+Skourides+D%2C+Ferentinos+P%2C+Havaki-Kontaxaki+BJ%2C+Papadimitriou+GN&amp;rft.aulast=Kontaxakis+VP%2C+Skourides+D%2C+Ferentinos+P%2C+Havaki-Kontaxaki+BJ%2C+Papadimitriou+GN&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.annals-general-psychiatry.com%2Fcontent%2F8%2F1%2F2&amp;rft_id=info%3Adoi%2F10.1186%2F1744-859X-8-2&amp;rft_id=info%3Apmid%2F19154613&amp;rft.issn=1744-859X&amp;rft.issue=1&amp;rft.jtitle=Annals+of+General+Psychiatry&amp;rft.pages=2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lambert_1989-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lambert_1989_59-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lambert RW, Smith RE (March 1989). "Effects of 13-cis-retinoic acid on the hamster meibomian gland". <i>J. Invest. Dermatol.</i> <b>92</b> (3): 321–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2F1523-1747.ep12277122">10.1111/1523-1747.ep12277122</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2918239">2918239</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Effects+of+13-cis-retinoic+acid+on+the+hamster+meibomian+gland&amp;rft.au=Lambert+RW%2C+Smith+RE&amp;rft.aulast=Lambert+RW%2C+Smith+RE&amp;rft.date=March+1989&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2F1523-1747.ep12277122&amp;rft_id=info%3Apmid%2F2918239&amp;rft.issue=3&amp;rft.jtitle=J.+Invest.+Dermatol.&amp;rft.pages=321-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=92" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kremer1994-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kremer1994_60-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kremer I, Gaton DD, David M, Gaton E, Shapiro A (1994). "Toxic effects of systemic retinoids on meibomian glands". <i>Ophthalmic Res.</i> <b>26</b> (2): 124–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000267402">10.1159/000267402</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8196934">8196934</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Toxic+effects+of+systemic+retinoids+on+meibomian+glands&amp;rft.au=Kremer+I%2C+Gaton+DD%2C+David+M%2C+Gaton+E%2C+Shapiro+A&amp;rft.aulast=Kremer+I%2C+Gaton+DD%2C+David+M%2C+Gaton+E%2C+Shapiro+A&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000267402&amp;rft_id=info%3Apmid%2F8196934&amp;rft.issue=2&amp;rft.jtitle=Ophthalmic+Res.&amp;rft.pages=124-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Griffin_2010-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-Griffin_2010_61-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Griffin JN, Pinali D, Olds K, Lu N, Appleby L, Doan L, Lane MA (November 2010). "13-Cis-retinoic acid decreases hypothalamic cell number in vitro". <i>Neurosci. Res.</i> <b>68</b> (3): 185–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.neures.2010.08.003">10.1016/j.neures.2010.08.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20708044">20708044</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=13-Cis-retinoic+acid+decreases+hypothalamic+cell+number+in+vitro&amp;rft.au=Griffin+JN%2C+Pinali+D%2C+Olds+K%2C+Lu+N%2C+Appleby+L%2C+Doan+L%2C+Lane+MA&amp;rft.aulast=Griffin+JN%2C+Pinali+D%2C+Olds+K%2C+Lu+N%2C+Appleby+L%2C+Doan+L%2C+Lane+MA&amp;rft.date=November+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neures.2010.08.003&amp;rft_id=info%3Apmid%2F20708044&amp;rft.issue=3&amp;rft.jtitle=Neurosci.+Res.&amp;rft.pages=185-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Crandall2004-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-Crandall2004_62-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P (April 2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC387382">"13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>101</b> (14): 5111–6. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2004PNAS..101.5111C">2004PNAS..101.5111C</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.0306336101">10.1073/pnas.0306336101</a>. <a href="/wiki/JSTOR" title="JSTOR">JSTOR</a>&#160;<a rel="nofollow" class="external text" href="//www.jstor.org/stable/3371827">3371827</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC387382">387382</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15051884">15051884</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=13-cis-retinoic+acid+suppresses+hippocampal+cell+division+and+hippocampal-dependent+learning+in+mice&amp;rft.au=Crandall+J%2C+Sakai+Y%2C+Zhang+J%2C+Koul+O%2C+Mineur+Y%2C+Crusio+WE%2C+McCaffery+P&amp;rft.aulast=Crandall+J%2C+Sakai+Y%2C+Zhang+J%2C+Koul+O%2C+Mineur+Y%2C+Crusio+WE%2C+McCaffery+P&amp;rft.date=April+2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC387382&amp;rft_id=info%3Abibcode%2F2004PNAS..101.5111C&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0306336101&amp;rft_id=info%3Apmc%2F387382&amp;rft_id=info%3Apmid%2F15051884&amp;rft.issue=14&amp;rft.jstor=3371827&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=5111-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sakai_2004-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sakai_2004_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sakai Y, Crandall JE, Brodsky J, McCaffery P (June 2004). "13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice". <i>Ann. N. Y. Acad. Sci.</i> <b>1021</b>: 436–40. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2004NYASA1021..436S">2004NYASA1021..436S</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1196%2Fannals.1308.059">10.1196/annals.1308.059</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15251924">15251924</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=13-cis+Retinoic+acid+%28accutane%29+suppresses+hippocampal+cell+survival+in+mice&amp;rft.aulast=Sakai+Y%2C+Crandall+JE%2C+Brodsky+J%2C+McCaffery+P&amp;rft.au=Sakai+Y%2C+Crandall+JE%2C+Brodsky+J%2C+McCaffery+P&amp;rft.date=June+2004&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F2004NYASA1021..436S&amp;rft_id=info%3Adoi%2F10.1196%2Fannals.1308.059&amp;rft_id=info%3Apmid%2F15251924&amp;rft.jtitle=Ann.+N.+Y.+Acad.+Sci.&amp;rft.pages=436-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1021" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nelson2011-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nelson2011_64-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nelson AM, Cong Z, Gilliland KL, Thiboutot DM (September 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444">"TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells"</a>. <i>Br. J. Dermatol.</i> <b>165</b> (3): 526–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2133.2011.10392.x">10.1111/j.1365-2133.2011.10392.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444">3166444</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21564055">21564055</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=TRAIL+contributes+to+the+apoptotic+effect+of+13-cis+retinoic+acid+in+human+sebaceous+gland+cells&amp;rft.aulast=Nelson+AM%2C+Cong+Z%2C+Gilliland+KL%2C+Thiboutot+DM&amp;rft.au=Nelson+AM%2C+Cong+Z%2C+Gilliland+KL%2C+Thiboutot+DM&amp;rft.date=September+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3166444&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2011.10392.x&amp;rft_id=info%3Apmc%2F3166444&amp;rft_id=info%3Apmid%2F21564055&amp;rft.issue=3&amp;rft.jtitle=Br.+J.+Dermatol.&amp;rft.pages=526-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=165" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nelson_2006-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nelson_2006_65-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nelson AM, Gilliland KL, Cong Z, Thiboutot DM (October 2006). "13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes". <i>J. Invest. Dermatol.</i> <b>126</b> (10): 2178–89. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.jid.5700289">10.1038/sj.jid.5700289</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16575387">16575387</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=13-cis+Retinoic+acid+induces+apoptosis+and+cell+cycle+arrest+in+human+SEB-1+sebocytes&amp;rft.aulast=Nelson+AM%2C+Gilliland+KL%2C+Cong+Z%2C+Thiboutot+DM&amp;rft.au=Nelson+AM%2C+Gilliland+KL%2C+Cong+Z%2C+Thiboutot+DM&amp;rft.date=October+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.jid.5700289&amp;rft_id=info%3Apmid%2F16575387&amp;rft.issue=10&amp;rft.jtitle=J.+Invest.+Dermatol.&amp;rft.pages=2178-89&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=126" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><span class="citation journal">Wachter K (2009). "Isotretinoin's Mechanism of Action Explored". <i>Skin &amp; Allergy News</i> <b>40</b> (11): 32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0037-6337%2809%2970553-4">10.1016/S0037-6337(09)70553-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Isotretinoin%27s+Mechanism+of+Action+Explored&amp;rft.aulast=Wachter+K&amp;rft.au=Wachter+K&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0037-6337%2809%2970553-4&amp;rft.issue=11&amp;rft.jtitle=Skin+%26+Allergy+News&amp;rft.pages=32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx">Isotretinoin’s Mechanism of Action Elucidated</a>. Medconnect (2009-08-28). Retrieved on 2010-11-13.</span></li>
<li id="cite_note-pmid18317594-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18317594_68-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM (April 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030">"Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells"</a>. <i>J. Clin. Invest.</i> <b>118</b> (4): 1468–78. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI33869">10.1172/JCI33869</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030">2262030</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18317594">18317594</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Neutrophil+gelatinase-associated+lipocalin+mediates+13-cis+retinoic+acid-induced+apoptosis+of+human+sebaceous+gland+cells&amp;rft.aulast=Nelson+AM%2C+Zhao+W%2C+Gilliland+KL%2C+Zaenglein+AL%2C+Liu+W%2C+Thiboutot+DM&amp;rft.au=Nelson+AM%2C+Zhao+W%2C+Gilliland+KL%2C+Zaenglein+AL%2C+Liu+W%2C+Thiboutot+DM&amp;rft.date=April+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2262030&amp;rft_id=info%3Adoi%2F10.1172%2FJCI33869&amp;rft_id=info%3Apmc%2F2262030&amp;rft_id=info%3Apmid%2F18317594&amp;rft.issue=4&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.pages=1468-78&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Peck-69"><span class="mw-cite-backlink">^ <a href="#cite_ref-Peck_69-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Peck_69-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, Butkus D, Arnaud-Battandier J (February 1979). "Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid". <i>N. Engl. J. Med.</i> <b>300</b> (7): 329–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM197902153000701">10.1056/NEJM197902153000701</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/153472">153472</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Prolonged+remissions+of+cystic+and+conglobate+acne+with+13-cis-retinoic+acid&amp;rft.aulast=Peck+GL%2C+Olsen+TG%2C+Yoder+FW%2C+Strauss+JS%2C+Downing+DT%2C+Pandya+M%2C+Butkus+D%2C+Arnaud-Battandier+J&amp;rft.au=Peck+GL%2C+Olsen+TG%2C+Yoder+FW%2C+Strauss+JS%2C+Downing+DT%2C+Pandya+M%2C+Butkus+D%2C+Arnaud-Battandier+J&amp;rft.date=February+1979&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM197902153000701&amp;rft_id=info%3Apmid%2F153472&amp;rft.issue=7&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=329-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=300" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Shalita A (2001). "The integral role of topical and oral retinoids in the early treatment of acne". <i>European Academy of Dermatology and Venereology (JEADV)</i> <b>15</b>: 47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.0926-9959.2001.00012.x">10.1046/j.0926-9959.2001.00012.x</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=The+integral+role+of+topical+and+oral+retinoids+in+the+early+treatment+of+acne&amp;rft.aulast=Shalita+A&amp;rft.au=Shalita+A&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.0926-9959.2001.00012.x&amp;rft.jtitle=European+Academy+of+Dermatology+and+Venereology+%28JEADV%29&amp;rft.pages=47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-FDA-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Roche Laboratories (September 2007). <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s060lbl.pdf">"Accutane (Isotretinoin Capsules)"</a> <span style="font-size:85%;">(PDF)</span>. <i>FDA-Approved Official Product Label</i> (U.S. Food and Drug Administration). NDA 018-662 S-058<span class="reference-accessdate">. Retrieved 05/02/2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Accutane+%28Isotretinoin+Capsules%29&amp;rft.aulast=Roche+Laboratories&amp;rft.au=Roche+Laboratories&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F018662s060lbl.pdf&amp;rft.jtitle=FDA-Approved+Official+Product+Label&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=NDA+018-662+S-058" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="font-size:100%" class="error citation-comment">Check date values in: <code style="color:inherit; border:inherit; padding:inherit;">|accessdate=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Farrell-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-Farrell_72-0">^</a></b></span> <span class="reference-text"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (August 2013)">unreliable medical source?</span></a></i>]</sup><span class="citation journal">Farrell LN, Strauss JS, Stranieri AM (December 1980). "The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial". <i>J. Am. Acad. Dermatol.</i> <b>3</b> (6): 602–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0190-9622%2880%2980074-0">10.1016/S0190-9622(80)80074-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6451637">6451637</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=The+treatment+of+severe+cystic+acne+with+13-cis-retinoic+acid.+Evaluation+of+sebum+production+and+the+clinical+response+in+a+multiple-dose+trial&amp;rft.au=Farrell+LN%2C+Strauss+JS%2C+Stranieri+AM&amp;rft.aulast=Farrell+LN%2C+Strauss+JS%2C+Stranieri+AM&amp;rft.date=December+1980&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0190-9622%2880%2980074-0&amp;rft_id=info%3Apmid%2F6451637&amp;rft.issue=6&amp;rft.jtitle=J.+Am.+Acad.+Dermatol.&amp;rft.pages=602-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jones-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jones_73-0">^</a></b></span> <span class="reference-text"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (August 2013)">unreliable medical source?</span></a></i>]</sup><span class="citation journal">Jones H, Blanc D, Cunliffe WJ (November 1980). "13-cis retinoic acid and acne". <i>Lancet</i> <b>2</b> (8203): 1048–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2880%2992273-4">10.1016/S0140-6736(80)92273-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6107678">6107678</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=13-cis+retinoic+acid+and+acne&amp;rft.au=Jones+H%2C+Blanc+D%2C+Cunliffe+WJ&amp;rft.aulast=Jones+H%2C+Blanc+D%2C+Cunliffe+WJ&amp;rft.date=November+1980&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2880%2992273-4&amp;rft_id=info%3Apmid%2F6107678&amp;rft.issue=8203&amp;rft.jtitle=Lancet&amp;rft.pages=1048-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Pendino-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pendino_74-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E (June 2001). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC34517">"Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>98</b> (12): 6662–7. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2001PNAS...98.6662P">2001PNAS...98.6662P</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.111464998">10.1073/pnas.111464998</a>. <a href="/wiki/JSTOR" title="JSTOR">JSTOR</a>&#160;<a rel="nofollow" class="external text" href="//www.jstor.org/stable/3055868">3055868</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC34517">34517</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11371621">11371621</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Retinoids+down-regulate+telomerase+and+telomere+length+in+a+pathway+distinct+from+leukemia+cell+differentiation&amp;rft.aulast=Pendino+F%2C+Flexor+M%2C+Delhommeau+F%2C+Buet+D%2C+Lanotte+M%2C+Segal-Bendirdjian+E&amp;rft.au=Pendino+F%2C+Flexor+M%2C+Delhommeau+F%2C+Buet+D%2C+Lanotte+M%2C+Segal-Bendirdjian+E&amp;rft.date=June+2001&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC34517&amp;rft_id=info%3Abibcode%2F2001PNAS...98.6662P&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.111464998&amp;rft_id=info%3Apmc%2F34517&amp;rft_id=info%3Apmid%2F11371621&amp;rft.issue=12&amp;rft.jstor=3055868&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=6662-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=98" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><span class="citation web">Φαχαντίδης, Παναγιώτης Ε. (2007). <a rel="nofollow" class="external text" href="http://invenio.lib.auth.gr/record/103970"><bdi lang="el">Η επίδραση της ισοτρετινοϊνης και των αναστολέων της 5α-αναγωγάσης στις μεταλλοπρωτεάσες του συνδετικού ιστού σε ασθενείς με ακμή</bdi> [The influence of isotretinoin and 5-a reductase inhibitors in metaloproteases of connective tissue in patients with ance]</a> (in Greek). <a href="/wiki/Aristotle_University_of_Thessaloniki" title="Aristotle University of Thessaloniki">Aristotle University of Thessaloniki</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.au=%CE%A6%CE%B1%CF%87%CE%B1%CE%BD%CF%84%CE%AF%CE%B4%CE%B7%CF%82%2C+%CE%A0%CE%B1%CE%BD%CE%B1%CE%B3%CE%B9%CF%8E%CF%84%CE%B7%CF%82+%CE%95.&amp;rft.aufirst=%CE%A0%CE%B1%CE%BD%CE%B1%CE%B3%CE%B9%CF%8E%CF%84%CE%B7%CF%82+%CE%95.&amp;rft.aulast=%CE%A6%CE%B1%CF%87%CE%B1%CE%BD%CF%84%CE%AF%CE%B4%CE%B7%CF%82&amp;rft.btitle=%CE%97+%CE%B5%CF%80%CE%AF%CE%B4%CF%81%CE%B1%CF%83%CE%B7+%CF%84%CE%B7%CF%82+%CE%B9%CF%83%CE%BF%CF%84%CF%81%CE%B5%CF%84%CE%B9%CE%BD%CE%BF%CF%8A%CE%BD%CE%B7%CF%82+%CE%BA%CE%B1%CE%B9+%CF%84%CF%89%CE%BD+%CE%B1%CE%BD%CE%B1%CF%83%CF%84%CE%BF%CE%BB%CE%AD%CF%89%CE%BD+%CF%84%CE%B7%CF%82+5%CE%B1-%CE%B1%CE%BD%CE%B1%CE%B3%CF%89%CE%B3%CE%AC%CF%83%CE%B7%CF%82+%CF%83%CF%84%CE%B9%CF%82+%CE%BC%CE%B5%CF%84%CE%B1%CE%BB%CE%BB%CE%BF%CF%80%CF%81%CF%89%CF%84%CE%B5%CE%AC%CF%83%CE%B5%CF%82+%CF%84%CE%BF%CF%85+%CF%83%CF%85%CE%BD%CE%B4%CE%B5%CF%84%CE%B9%CE%BA%CE%BF%CF%8D+%CE%B9%CF%83%CF%84%CE%BF%CF%8D+%CF%83%CE%B5+%CE%B1%CF%83%CE%B8%CE%B5%CE%BD%CE%B5%CE%AF%CF%82+%CE%BC%CE%B5+%CE%B1%CE%BA%CE%BC%CE%AE&amp;rft.date=2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Finvenio.lib.auth.gr%2Frecord%2F103970&amp;rft.pub=Aristotle+University+of+Thessaloniki&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (April 2012)">unreliable medical source?</span></a></i>]</sup></span></li>
<li id="cite_note-pmid12102663-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12102663_76-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M (June 2002). "Sebaceous glands in acne patients express high levels of neutral endopeptidase". <i>Exp. Dermatol.</i> <b>11</b> (3): 241–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1034%2Fj.1600-0625.2002.110307.x">10.1034/j.1600-0625.2002.110307.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12102663">12102663</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Sebaceous+glands+in+acne+patients+express+high+levels+of+neutral+endopeptidase&amp;rft.aulast=Toyoda+M%2C+Nakamura+M%2C+Makino+T%2C+Kagoura+M%2C+Morohashi+M&amp;rft.au=Toyoda+M%2C+Nakamura+M%2C+Makino+T%2C+Kagoura+M%2C+Morohashi+M&amp;rft.date=June+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1034%2Fj.1600-0625.2002.110307.x&amp;rft_id=info%3Apmid%2F12102663&amp;rft.issue=3&amp;rft.jtitle=Exp.+Dermatol.&amp;rft.pages=241-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-drugs.com-77"><span class="mw-cite-backlink">^ <a href="#cite_ref-drugs.com_77-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-drugs.com_77-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-drugs.com_77-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-drugs.com_77-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-drugs.com_77-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.drugs.com/pro/accutane.html">"FDA information, side effects, and uses / Accutane (isotretinoin)"</a>. U. S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=FDA+information%2C+side+effects%2C+and+uses+%2F+Accutane+%28isotretinoin%29&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.drugs.com%2Fpro%2Faccutane.html&amp;rft.pub=U.+S.+Food+and+Drug+Administration+%28FDA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.drugs.com/pro/accutane.html#T_2">"FDA information, side effects, and uses / Accutane (isotretinoin)&#160;: <b>Table 2 Pharmacokinetic Parameters of Isotretinoin Mean (%CV), N=74</b>"</a>. U. S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=FDA+information%2C+side+effects%2C+and+uses+%2F+Accutane+%28isotretinoin%29+%3A+Table+2+Pharmacokinetic+Parameters+of+Isotretinoin+Mean+%28%25CV%29%2C+N%3D74&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.drugs.com%2Fpro%2Faccutane.html%23T_2&amp;rft.pub=U.+S.+Food+and+Drug+Administration+%28FDA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.drugs.com/pro/accutane.html#Drug_Interactions">"FDA information, side effects, and uses / Accutane (isotretinoin)&#160;: <b>Drug Interactions</b>"</a>. U. S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=FDA+information%2C+side+effects%2C+and+uses+%2F+Accutane+%28isotretinoin%29+%3A+Drug+Interactions&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.drugs.com%2Fpro%2Faccutane.html%23Drug_Interactions&amp;rft.pub=U.+S.+Food+and+Drug+Administration+%28FDA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Green-80"><span class="mw-cite-backlink">^ <a href="#cite_ref-Green_80-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Green_80-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Green_80-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Green, Julia (March 2002). <a rel="nofollow" class="external text" href="http://dash.harvard.edu/handle/1/8963867">"Babies, Blemishes and FDA: A History of Accutane Regulation in the United States"</a>. <i>Digital Access to Scholarship at Harvard</i>. Harvard Law School<span class="reference-accessdate">. Retrieved <span class="nowrap">19 April</span> 2015</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Babies%2C+Blemishes+and+FDA%3A+A+History+of+Accutane+Regulation+in+the+United+States&amp;rft.aufirst=Julia&amp;rft.au=Green%2C+Julia&amp;rft.aulast=Green&amp;rft.date=March+2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fdash.harvard.edu%2Fhandle%2F1%2F8963867&amp;rft.jtitle=Digital+Access+to+Scholarship+at+Harvard&amp;rft.pub=Harvard+Law+School&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text">Gina Kolata for the New York Times. April 22, 1988 <a rel="nofollow" class="external text" href="http://www.nytimes.com/1988/04/22/us/anti-acne-drug-faulted-in-birth-defects.html?pagewanted=all">Anti-Acne Drug Faulted in Birth</a></span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text">CDC. January 21, 2000 <a rel="nofollow" class="external text" href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4902a2.htm">Accutane®-Exposed Pregnancies -- California, 1999</a> MMWR Weekly 49(02);28-31</span></li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><span class="citation pressrelease"><a rel="nofollow" class="external text" href="http://www.gene.com/gene/products/information/accutane/">"Roche Discontinues and Plans to Delist Accutane in the U.S."</a> (Press release). <a href="/wiki/Genentech" title="Genentech">Genentech</a>. 2009-06-29<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-12</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.btitle=Roche+Discontinues+and+Plans+to+Delist+Accutane+in+the+U.S.&amp;rft.date=2009-06-29&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.gene.com%2Fgene%2Fproducts%2Finformation%2Faccutane%2F&amp;rft.pub=Genentech&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation news">Feeley J (2011-03-11). <a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2011-03-10/roche-s-accutane-caused-tragedy-for-actor-brian-dennehy-says.html">"Roche Accutane Acne Drug Caused 'Tragedy' for Actor, Brian Dennehy Says"</a>. <i>Bloomberg</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Roche+Accutane+Acne+Drug+Caused+%27Tragedy%27+for+Actor%2C+Brian+Dennehy+Says&amp;rft.au=Feeley+J&amp;rft.aulast=Feeley+J&amp;rft.date=2011-03-11&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2011-03-10%2Froche-s-accutane-caused-tragedy-for-actor-brian-dennehy-says.html&amp;rft.jtitle=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlIts_Curtains_On_Actors_Accutane_Lawsuit_.7C_Pharmalot-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlIts_Curtains_On_Actors_Accutane_Lawsuit_.7C_Pharmalot_85-0">^</a></b></span> <span class="reference-text"><span class="citation web">Silverman E (2011-11-04). <a rel="nofollow" class="external text" href="http://www.pharmalive.com/its-curtains-actors-accutane-lawsuit">"It's Curtains On Actor's Accutane Lawsuit"</a>. <i>Pharmalot</i>. UBM Canon.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=It%27s+Curtains+On+Actor%27s+Accutane+Lawsuit&amp;rft.aulast=Silverman+E&amp;rft.au=Silverman+E&amp;rft.date=2011-11-04&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.pharmalive.com%2Fits-curtains-actors-accutane-lawsuit&amp;rft.jtitle=Pharmalot&amp;rft.pub=UBM+Canon&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation news">Voreacos D (May 30, 2007). <a rel="nofollow" class="external text" href="http://www.washingtonpost.com/wp-dyn/content/article/2007/05/29/AR2007052901946.html">"Roche Found Liable in First Of 400 Suits Over Accutane"</a>. <i>The Washington Post</i>. Bloomberg News<span class="reference-accessdate">. Retrieved <span class="nowrap">April 30,</span> 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.atitle=Roche+Found+Liable+in+First+Of+400+Suits+Over+Accutane&amp;rft.aulast=Voreacos+D&amp;rft.au=Voreacos+D&amp;rft.date=May+30%2C+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2007%2F05%2F29%2FAR2007052901946.html&amp;rft.jtitle=The+Washington+Post&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><span class="citation web">Shari Roan (7 November 2009). <a rel="nofollow" class="external text" href="http://www.latimes.com/nation/la-sci-accutane7-2009nov07-story.html#page=1">"New study may deal final blow to acne drug Accutane"</a>. <a href="/wiki/LA_Times" title="LA Times" class="mw-redirect">LA Times</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIsotretinoin&amp;rft.aulast=Shari+Roan&amp;rft.au=Shari+Roan&amp;rft.btitle=New+study+may+deal+final+blow+to+acne+drug+Accutane&amp;rft.date=7+November+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.latimes.com%2Fnation%2Fla-sci-accutane7-2009nov07-story.html%23page%3D1&amp;rft.pub=LA+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h3><span class="mw-headline" id="Drugs.40FDA_references">Drugs@FDA references</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=15" title="Edit section: Drugs@FDA references">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><i>The following are queries against the Drugs@FDA database used as references.</i></p>
<div class="reflist" style="list-style-type: decimal;">
<ol class="references">
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text">For Roche's Accutane see <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&amp;DrugName=ACCUTANE">database query</a> run 3 August 2014.</span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text">For Mylan's Amnesteem see <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&amp;DrugName=AMNESTEEM">database query</a> run 3 August 2014.</span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text">For Teva's Claravis see <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&amp;DrugName=CLARAVIS">database query</a> run 3 August 2014.</span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text">For Ranbaxy's Absorica see <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&amp;DrugName=ABSORICA">database query</a> run 2 August 2014.</span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=018662&amp;DrugName=ACCUTANE&amp;ActiveIngred=ISOTRETINOIN&amp;SponsorApplicant=HOFFMANN%20LA%20ROCHE&amp;ProductMktStatus=3&amp;goto=Search.Label_ApprovalHistory">Label and approval history</a> for Roche's Accutane, retrieved 3 August 2014.</span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Isotretinoin&amp;action=edit&amp;section=16" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.drugs.com/MTM/isotretinoin.html">Drugs.com Isotretinoin Information</a></li>
<li><a rel="nofollow" class="external text" href="http://dermatology.cdlib.org/95/letters/isotretinoin/danby.html">Dermatology Vol 9: issue 5: Night blindness, vitamin A deficiency, and isotretinoin psychotoxicity</a></li>
<li><a href="/wiki/New_Zealand_Dermatological_Society" title="New Zealand Dermatological Society">DermNet</a> <i><a rel="nofollow" class="external text" href="http://dermnetnz.org/treatments/isotretinoin.html">treatments/isotretinoin</a></i></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Carotenoids" title="Template:Carotenoids"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Carotenoids" title="Template talk:Carotenoids"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Carotenoids&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Carotenoid" title="Carotenoid">Carotenoids</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Carotene" title="Carotene">Carotenes</a> (C<sub>40</sub>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alpha-Carotene" title="Alpha-Carotene">α-Carotene</a></li>
<li><a href="/wiki/Beta-Carotene" title="Beta-Carotene">β-Carotene</a></li>
<li><a href="/wiki/Gamma-Carotene" title="Gamma-Carotene">γ-Carotene</a></li>
<li><a href="/wiki/Delta-Carotene" title="Delta-Carotene">δ-Carotene</a></li>
<li><a href="/wiki/Epsilon-Carotene" title="Epsilon-Carotene">ε-Carotene</a></li>
<li><a href="/wiki/Zeta-Carotene" title="Zeta-Carotene">ζ-Carotene</a></li>
<li><a href="/wiki/Lycopene" title="Lycopene">Lycopene</a></li>
<li><a href="/wiki/Neurosporene" title="Neurosporene">Neurosporene</a></li>
<li><a href="/wiki/Phytoene" title="Phytoene">Phytoene</a></li>
<li><a href="/wiki/Phytofluene" title="Phytofluene">Phytofluene</a></li>
<li><a href="/wiki/Torulene" title="Torulene">Torulene</a></li>
<li><a href="/w/index.php?title=Lycopersene&amp;action=edit&amp;redlink=1" class="new" title="Lycopersene (page does not exist)">Lycopersene</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Xanthophyll" title="Xanthophyll">Xanthophylls</a> (C<sub>40</sub>)</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Antheraxanthin" title="Antheraxanthin">Antheraxanthin</a></li>
<li><a href="/wiki/Astaxanthin" title="Astaxanthin">Astaxanthin</a></li>
<li><a href="/wiki/Canthaxanthin" title="Canthaxanthin">Canthaxanthin</a></li>
<li><a href="/wiki/Citranaxanthin" title="Citranaxanthin">Citranaxanthin</a></li>
<li><a href="/wiki/Cryptoxanthin" title="Cryptoxanthin">Cryptoxanthin</a></li>
<li><a href="/wiki/Diadinoxanthin" title="Diadinoxanthin">Diadinoxanthin</a></li>
<li><a href="/wiki/Diatoxanthin" title="Diatoxanthin">Diatoxanthin</a></li>
<li><a href="/wiki/Dinoxanthin" title="Dinoxanthin">Dinoxanthin</a></li>
<li><a href="/wiki/Echinenone" title="Echinenone">Echinenone</a></li>
<li><a href="/wiki/Flavoxanthin" title="Flavoxanthin">Flavoxanthin</a></li>
<li><a href="/wiki/Fucoxanthin" title="Fucoxanthin">Fucoxanthin</a></li>
<li><a href="/wiki/Lutein" title="Lutein">Lutein</a></li>
<li><a href="/wiki/Neoxanthin" title="Neoxanthin">Neoxanthin</a></li>
<li><a href="/wiki/Rhodoxanthin" title="Rhodoxanthin">Rhodoxanthin</a></li>
<li><a href="/wiki/Rubixanthin" title="Rubixanthin">Rubixanthin</a></li>
<li><a href="/wiki/Violaxanthin" title="Violaxanthin">Violaxanthin</a></li>
<li><a href="/wiki/Zeaxanthin" title="Zeaxanthin">Zeaxanthin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Apocarotenoid" title="Apocarotenoid">Apocarotenoids</a> (C<sub>&lt;40</sub>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Abscisic_acid" title="Abscisic acid">Abscisic acid</a></li>
<li><a href="/wiki/Apocarotenal" title="Apocarotenal">Apocarotenal</a></li>
<li><a href="/wiki/Bixin" title="Bixin">Bixin</a></li>
<li><a href="/wiki/Crocetin" title="Crocetin">Crocetin</a></li>
<li><a href="/wiki/Food_orange_7" title="Food orange 7">Food orange 7</a></li>
<li><a href="/wiki/Ionone" title="Ionone">Ionones</a></li>
<li><a href="/wiki/Peridinin" title="Peridinin">Peridinin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Vitamin A retinoids (C<sub>20</sub>)</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Retinal" title="Retinal">Retinal</a></li>
<li><a href="/wiki/Retinoic_acid" title="Retinoic acid">Retinoic acid</a></li>
<li><a href="/wiki/Retinol" title="Retinol">Retinol</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Retinoid" title="Retinoid">Retinoid drugs</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acitretin" title="Acitretin">Acitretin</a></li>
<li><a href="/wiki/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="/wiki/Bexarotene" title="Bexarotene">Bexarotene</a></li>
<li><a href="/wiki/Etretinate" title="Etretinate">Etretinate</a></li>
<li><a href="/wiki/Fenretinide" title="Fenretinide">Fenretinide</a></li>
<li><strong class="selflink">Isotretinoin</strong></li>
<li><a href="/wiki/Tazarotene" title="Tazarotene">Tazarotene</a></li>
<li><a href="/wiki/Tretinoin" title="Tretinoin">Tretinoin</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Acne_agents" title="Template:Acne agents"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Acne_agents" title="Template talk:Acne agents"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Acne_agents&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Acne_vulgaris" title="Acne vulgaris">Acne</a>-treating agents (<a href="/wiki/ATC_code_D10" title="ATC code D10">D10</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Antiseptic" title="Antiseptic">Antibacterial</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Azelaic_acid" title="Azelaic acid">Azelaic acid</a></li>
<li><a href="/wiki/Benzoyl_peroxide" title="Benzoyl peroxide">Benzoyl peroxide</a><sup>#</sup></li>
<li><a href="/wiki/8-Hydroxyquinoline" title="8-Hydroxyquinoline">8-Hydroxyquinoline</a></li>
<li><a href="/wiki/Light_therapy" title="Light therapy">Blue light therapy</a></li>
<li><a href="/wiki/Tea_tree_oil" title="Tea tree oil">Tea tree oil</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Keratolytic" title="Keratolytic">Keratolytic</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Glycolic_acid" title="Glycolic acid">Glycolic acid</a></li>
<li><a href="/wiki/Salicylic_acid" title="Salicylic acid">Salicylic acid</a><sup>#</sup></li>
<li><a href="/wiki/Sulfur" title="Sulfur">Sulfur</a></li>
<li><a href="/wiki/Benzoyl_peroxide" title="Benzoyl peroxide">Benzoyl peroxide</a><sup>#</sup></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">Anti-inflammatory</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Nicotinamide" title="Nicotinamide">Nicotinamide</a></li>
<li><a href="/wiki/Ibuprofen" title="Ibuprofen">Ibuprofen</a> #</li>
<li><a href="/wiki/Aspirin" title="Aspirin">Aspirin</a> #</li>
<li><a href="/wiki/Light_therapy" title="Light therapy">Red light therapy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Antibiotics" title="Antibiotics">Antibiotics</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li><a href="/wiki/Dapsone" title="Dapsone">Dapsone</a></li>
<li><a href="/wiki/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li><a href="/wiki/Sulfacetamide" title="Sulfacetamide">Sulfacetamide</a></li>
<li><a href="/wiki/Tetracycline_antibiotics" title="Tetracycline antibiotics">Tetracyclines</a> (<a href="/wiki/Lymecycline" title="Lymecycline">Lymecycline</a></li>
<li><a href="/wiki/Minocycline" title="Minocycline">Minocycline</a></li>
<li><a href="/wiki/Doxycycline" title="Doxycycline">Doxycycline</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hormone" title="Hormone">Hormonal</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></li>
<li><a href="/wiki/Combined_oral_contraceptive_pill" title="Combined oral contraceptive pill">Contraceptives</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Retinoid" title="Retinoid">Retinoids</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Adapalene" title="Adapalene">Adapalene</a></li>
<li><strong class="selflink">Isotretinoin</strong></li>
<li><a href="/wiki/Motretinide" title="Motretinide">Motretinide</a></li>
<li><a href="/wiki/Tazarotene" title="Tazarotene">Tazarotene</a></li>
<li><a href="/wiki/Tretinoin" title="Tretinoin">Tretinoin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Benzamycin" title="Benzamycin">Benzamycin</a></li>
<li><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></li>
<li><a href="/wiki/Mesulfen" title="Mesulfen">Mesulfen</a></li>
<li><a href="/wiki/Pelretin" title="Pelretin">Pelretin</a></li>
<li><a href="/wiki/Stridex" title="Stridex">Stridex</a></li>
<li><a href="/wiki/Tioxolone" title="Tioxolone">Tioxolone</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Combinations</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Adapalene/benzoyl_peroxide" title="Adapalene/benzoyl peroxide">Adapalene/benzoyl peroxide</a></li>
<li><a href="/wiki/Benzoyl_peroxide/clindamycin" title="Benzoyl peroxide/clindamycin">Benzoyl peroxide/clindamycin</a></li>
<li><a href="/wiki/Clindamycin/tretinoin" title="Clindamycin/tretinoin">Clindamycin/tretinoin</a></li>
<li><a href="/wiki/Erythromycin/isotretinoin" title="Erythromycin/isotretinoin">Erythromycin/isotretinoin</a></li>
<li><a href="/wiki/Sulfacetamide/sulfur" title="Sulfacetamide/sulfur">Sulfacetamide/sulfur</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>
<div class="hlist"></div>
</li>
<li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul>
<li><sup>†</sup><a href="/wiki/Clinical_trial#Phase_III" title="Clinical trial">Phase III</a></li>
<li><sup>§</sup><a href="/wiki/Clinical_trial#Phase_II" title="Clinical trial">Never to phase III</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Skin_appendage_navs" title="Template:Skin appendage navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Skin_appendage_navs" title="Template talk:Skin appendage navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Skin_appendage_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Skin_appendage" title="Skin appendage">skin appendages</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Integumentary_system" title="Template:Integumentary system">Anatomy</a></li>
<li><a href="/wiki/Template:Integumentary_physiology" title="Template:Integumentary physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_integument" title="Template:Development of integument">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_skin_appendages" title="Template:Congenital malformations and deformations of skin appendages">Congenital</a></li>
<li><a href="/wiki/Template:Tumors_of_skin_appendages" title="Template:Tumors of skin appendages">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Disorders_of_skin_appendages" title="Template:Disorders of skin appendages">Other</a></li>
<li><a href="/wiki/Template:Skin_and_subcutaneous_tissue_symptoms_and_signs" title="Template:Skin and subcutaneous tissue symptoms and signs">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Skin_and_subcutaneous_tissue_procedures" title="Template:Skin and subcutaneous tissue procedures">Procedures</a></li>
<li><a href="/wiki/Template:Acne_agents" title="Template:Acne agents">Acne drugs</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1008
CPU time usage: 1.370 seconds
Real time usage: 1.543 seconds
Preprocessor visited node count: 8234/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 263606/2097152 bytes
Template argument size: 11730/2097152 bytes
Highest expansion depth: 20/40
Expensive parser function count: 6/500
Lua time usage: 0.560/10.000 seconds
Lua memory usage: 4.37 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1295.089      1 - -total
 52.46%  679.426      2 - Template:Reflist
 30.91%  400.258      3 - Template:Infobox
 29.99%  388.441      1 - Template:Drugbox
 23.48%  304.113     54 - Template:Cite_journal
  7.73%  100.170     14 - Template:Fix
  6.48%   83.911     20 - Template:Category_handler
  4.36%   56.442     11 - Template:Cite_web
  4.23%   54.751      6 - Template:Page_needed
  3.75%   48.542      3 - Template:Navbox
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:229985-0!*!0!!en!4!* and timestamp 20150706195025 and revision id 670094164
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Isotretinoin&amp;oldid=670094164">https://en.wikipedia.org/w/index.php?title=Isotretinoin&amp;oldid=670094164</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Retinoids" title="Category:Retinoids">Retinoids</a></li><li><a href="/wiki/Category:Anti-acne_preparations" title="Category:Anti-acne preparations">Anti-acne preparations</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Wikipedia_articles_needing_page_number_citations_from_October_2010" title="Category:Wikipedia articles needing page number citations from October 2010">Wikipedia articles needing page number citations from October 2010</a></li><li><a href="/wiki/Category:Wikipedia_articles_needing_page_number_citations_from_May_2012" title="Category:Wikipedia articles needing page number citations from May 2012">Wikipedia articles needing page number citations from May 2012</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_August_2013" title="Category:Articles lacking reliable references from August 2013">Articles lacking reliable references from August 2013</a></li><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:CS1_errors:_dates" title="Category:CS1 errors: dates">CS1 errors: dates</a></li><li><a href="/wiki/Category:CS1_uses_Greek-language_script_(el)" title="Category:CS1 uses Greek-language script (el)">CS1 uses Greek-language script (el)</a></li><li><a href="/wiki/Category:CS1_Greek-language_sources_(el)" title="Category:CS1 Greek-language sources (el)">CS1 Greek-language sources (el)</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_April_2012" title="Category:Articles lacking reliable references from April 2012">Articles lacking reliable references from April 2012</a></li><li><a href="/wiki/Category:Chemical_articles_having_calculated_molecular_weight_overwritten" title="Category:Chemical articles having calculated molecular weight overwritten">Chemical articles having calculated molecular weight overwritten</a></li><li><a href="/wiki/Category:Drugboxes_which_contain_changes_to_watched_fields" title="Category:Drugboxes which contain changes to watched fields">Drugboxes which contain changes to watched fields</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_August_2013" title="Category:Articles with unsourced statements from August 2013">Articles with unsourced statements from August 2013</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Isotretinoin&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Isotretinoin" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Isotretinoin"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Isotretinoin"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Isotretinoin" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Isotretinoin&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Isotretinoin&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Isotretinoin" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Isotretinoin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Isotretinoin&amp;oldid=670094164" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Isotretinoin&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q287029" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Isotretinoin&amp;id=670094164" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Isotretinoin">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Isotretinoin&amp;oldid=670094164&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Isotretinoin&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%A2%D9%8A%D8%B2%D9%88%D8%AA%D8%B1%D9%8A%D8%AA%D9%8A%D9%86%D9%88%D9%8A%D9%86" title="آيزوتريتينوين – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Isotretinoin" title="Isotretinoin – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-et"><a href="//et.wikipedia.org/wiki/Isotretinoiin" title="Isotretinoiin – Estonian" lang="et" hreflang="et">Eesti</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Isotretino%C3%ADna" title="Isotretinoína – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%A7%DB%8C%D8%B2%D9%88%D8%AA%D8%B1%D8%AA%DB%8C%D9%86%D9%88%DB%8C%D9%86" title="ایزوترتینوین – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Isotr%C3%A9tino%C3%AFne" title="Isotrétinoïne – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Isotretinoina" title="Isotretinoina – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%90%D7%99%D7%96%D7%95%D7%98%D7%A8%D7%98%D7%99%D7%A0%D7%95%D7%90%D7%99%D7%9F" title="איזוטרטינואין – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Isotretino%C3%AFne" title="Isotretinoïne – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Izotretynoina" title="Izotretynoina – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Isotretino%C3%ADna" title="Isotretinoína – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%98%D0%B7%D0%BE%D1%82%D1%80%D0%B5%D1%82%D0%B8%D0%BD%D0%BE%D0%B8%D0%BD" title="Изотретиноин – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Izotretinoin" title="Izotretinoin – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Izotretinoin" title="Izotretinoin – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Izotretinoin" title="Izotretinoin – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Isotretinoiini" title="Isotretinoiini – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Isotretinoin" title="Isotretinoin – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-te"><a href="//te.wikipedia.org/wiki/%E0%B0%90%E0%B0%B8%E0%B1%8B%E0%B0%9F%E0%B1%8D%E0%B0%B0%E0%B0%BF%E0%B0%9F%E0%B0%BF%E0%B0%A8%E0%B1%8B%E0%B0%AF%E0%B0%BF%E0%B0%A8%E0%B1%8D" title="ఐసోట్రిటినోయిన్ – Telugu" lang="te" hreflang="te">తెలుగు</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E7%95%B0%E7%B6%ADA%E9%85%B8" title="異維A酸 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q287029#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 5 July 2015, at 20:15.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Isotretinoin&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":79,"wgHostname":"mw1254"});
}</script>
	</body>
</html>
